| TITLE |
DATE |
| Abbott Declares 352nd Consecutive Quarterly Dividend |
9-Dec-2011 |
| Abbott Initiates Clinical Trial to Evaluate the Absorb(TM) Bioresorbable Vascular Scaffold Compared to a Metallic Drug Eluting Stent |
8-Dec-2011 |
| Abbott Receives FDA Clearance for New Test to Detect Vitamin D Levels |
30-Nov-2011 |
| Abbott Expands Agreement with GSK to Include Development of a Companion Diagnostic Test for an Additional Investigational Cancer Immunotherapy Antigen |
28-Nov-2011 |
| Abbott Introduces the First FDA-Approved Supplemental Blood Test for Chagas Disease |
21-Nov-2011 |
| Abbott Statement on the Results of the AIM-HIGH Study Presented at AHA 2011 |
15-Nov-2011 |
| New Data Reinforce Clinical Performance of Abbott's ABSORB Bioresorbable Vascular Scaffold |
14-Nov-2011 |
| Abbott Reports Five-Year Data for HUMIRA® (Adalimumab) in Ankylosing Spondylitis |
8-Nov-2011 |
| Abbott Presents HUMIRA® (Adalimumab) Phase 3 Study Results for Patients with Active Non-Radiographic Axial Spondyloarthritis |
7-Nov-2011 |
| Abbott Announces New Long-Term Data Evaluating Use of HUMIRA® (Adalimumab) for Patients with Long-Standing Moderate to Severe Rheumatoid Arthritis and for Patients with Early Moderate to Severe RA |
6-Nov-2011 |
| Abbott Announces Winners of "CFChef Challenge" Recipe Contest as Part of Online Nutrition Resource for People Affected by Cystic Fibrosis |
4-Nov-2011 |
| Abbott Honored With Scrip Award for Leadership in Corporate Social Responsibility |
4-Nov-2011 |
| PATH, Abbott and the Abbott Fund Form Innovative Partnership to Prevent Malnutrition |
3-Nov-2011 |
| Abbott to Present New Data for Key Vascular Products at TCT 2011 |
3-Nov-2011 |
| Abbott to Present at 2011 Credit Suisse Annual Health Care Conference |
2-Nov-2011 |
| Abbott to Present Broad Spectrum of Compelling Data for HUMIRA® (Adalimumab) at American College of Rheumatology Annual Scientific Meeting |
2-Nov-2011 |
| Abbott Receives U.S. FDA Approval for Next-Generation XIENCE PRIME(TM) Drug Eluting Stent |
1-Nov-2011 |
| Abbott Launches Glucerna® Hunger Smart(TM) Nutrition Products for People with Diabetes |
27-Oct-2011 |
| Abbott Awards CFCareForward Scholarships to Two Students Living With Cystic Fibrosis Pursuing Undergraduate and Graduate Degrees |
25-Oct-2011 |
| Abbott's Genetic Test for Acute Myeloid Leukemia Prognosis Cleared by FDA |
24-Oct-2011 |
| Abbott Honored With Asian CSR Award for Leadership in Science Education |
24-Oct-2011 |
| Abbott Reports Strong Ongoing Third Quarter Results; Confirms Double-Digit Ongoing Earnings Growth Outlook for 2011 |
19-Oct-2011 |
| Abbott to Separate into Two Leading Companies in Diversified Medical Products and Research-Based Pharmaceuticals |
19-Oct-2011 |
| Abbott's ABSORB(TM) Bioresorbable Vascular Scaffold Honored with Wall Street Journal Technology Innovation Award |
17-Oct-2011 |
| Abbott Hosts Conference Call for Third-Quarter Earnings |
5-Oct-2011 |
| Abbott Enrolls First U.S. Patient in Global EXCEL Trial Comparing XIENCE to Coronary Artery Bypass Surgery |
4-Oct-2011 |
| Abbott Named Top Dealmaker for Fourth Consecutive Year by The Deal |
20-Sep-2011 |
| Abbott Earns 100 Percent Banned Substance Free Certification for all of its EAS® Sports Nutrition Products |
20-Sep-2011 |
| Abbott Again Recognized as One of the "Top Employers" in the Biotech and Pharmaceutical Industry by Science Magazine |
15-Sep-2011 |
| Abbott Declares 351st Consecutive Quarterly Dividend |
15-Sep-2011 |
| Abbott Named to Working Mother Magazine's 'Best Companies' List for the Eleventh Consecutive Year |
15-Sep-2011 |
| Abbott Named to the Dow Jones Sustainability Indexes for Seventh Consecutive Year in Recognition of Leading Corporate Citizenship Performance |
8-Sep-2011 |
| Abbott Initiates International ABSORB BTK Clinical Trial for Treatment of Below-the-Knee Critical Limb Ischemia |
8-Sep-2011 |
| Abbott to Present at Morgan Stanley Global Healthcare Conference |
31-Aug-2011 |
| Abbott Awards CFCareForward Scholarships to 40 Exceptional Graduate and Undergraduate Students Living with Cystic Fibrosis |
30-Aug-2011 |
| Abbott Receives FDA Approval for ALK Gene Test for Lung Cancer Therapy Selection |
26-Aug-2011 |
| Abbott Receives CE Mark for Healon EndoCoat Protective Gel for Cataract Surgery |
22-Aug-2011 |
| FDA Clears Abbott's Genetic FISH Panel for Leukemia Patient Prognosis |
22-Aug-2011 |
| Abbott Receives FDA Approval for Two Three-Month Strengths of Lupron Depot-PED® (leuprolide acetate for depot suspension) for the Treatment of Central Precocious Puberty (CPP) |
16-Aug-2011 |
| Abbott Expanding Manufacturing Capacity in China to Meet Demands of Fast-Growing Nutrition Market |
16-Aug-2011 |
| First Patient in Japan Treated with Abbott's Bioresorbable Vascular Scaffold as Part of Global Clinical Trial |
16-Aug-2011 |
| Abbott's PediaSure® Brand Aims to Help Moms With Picky Eaters "Take Back the Table" By Building Lifelong Healthy Eating Habits |
11-Aug-2011 |
| Abbott Introduces Vector-borne Pathogen Test to Detect Microorganisms Carried by Ticks and Other Insects |
10-Aug-2011 |
| Abbott Receives U.S. FDA Approval for RX Herculink Elite® Renal Stent System for Treatment of Renal Artery Disease |
10-Aug-2011 |
| Data Presented at American Association for Clinical Chemistry Meeting Show Many Americans May Have Low Vitamin D Levels |
28-Jul-2011 |
| Abbott's HIV Combo Test Detects Infections Earlier, Provides Valuable Information to Help Prevent Further HIV Transmission and May Save Treatment Costs |
27-Jul-2011 |
| Abbott to Feature Acute HIV Diagnostic, Metabolic Function Tests and Lab Informatics at American Association for Clinical Chemistry Annual Meeting |
21-Jul-2011 |
| Abbott Reports 11 Percent Ongoing Earnings-Per-Share Growth in Second Quarter; Raises 2011 EPS Guidance Range |
20-Jul-2011 |
| Abbott Hosts Conference Call for Second-Quarter Earnings |
29-Jun-2011 |
| Information Notice on Stolen Abbott Diabetes Care Blood Glucose Monitoring Products |
24-Jun-2011 |
| New Phase 2 Data Published in New England Journal of Medicine Show Bardoxolone Methyl Sustained Improvement in Measure of Kidney Function (eGFR) Over 52 Weeks in Patients With Moderate to Severe Chronic Kidney Disease and Type 2 Diabetes |
24-Jun-2011 |
| Abbott and Biotest Announce Global Agreement to Develop and Commercialize Novel Antibody for Autoimmune Diseases |
21-Jun-2011 |
| Abbott Receives FDA Approval for a New Six-Month Formulation of Lupron Depot® (leuprolide acetate for depot suspension) for the Palliative Treatment of Advanced Prostate Cancer |
20-Jun-2011 |
| Reata and Abbott Initiate Global Phase 3 Study of Bardoxolone Methyl in Patients With Chronic Kidney Disease and Type 2 Diabetes |
16-Jun-2011 |
| Abbott Receives FDA Approval for CREON® (Pancrelipase) Infant-Specific Dosage for Patients With Exocrine Pancreatic Insufficiency Due to Cystic Fibrosis |
14-Jun-2011 |
| New National Survey Results Reveal Majority of Men Find It Easier to Care for Their Car Than for Their Personal Health |
13-Jun-2011 |
| Abbott Declares 350th Consecutive Quarterly Dividend |
10-Jun-2011 |
| Abbott Reports Interim Results From Phase III Open-Label Study of Investigational Treatment for Advanced Parkinson's Disease |
9-Jun-2011 |
| Abbott Statement on Interim Study Results of AIM-HIGH |
26-May-2011 |
| Abbott to Present at Goldman Sachs 32nd Annual Global Healthcare Conference |
25-May-2011 |
| Abbott Receives U.S. FDA Approval for XIENCE nano(TM) to Treat Coronary Artery Disease in Small Vessels |
24-May-2011 |
| Abbott Completes Submission of New Molecular Test Intended for Non-small-cell Lung Cancer Therapy Selection |
23-May-2011 |
| Abbott Introduces New ZonePerfect® Sweet & Salty Nutrition Bars |
20-May-2011 |
| Abbott Statement on the FDA Advisory Committee Recommendations on Fenofibric Acid |
19-May-2011 |
| Study Shows Improved Patient Management and Outcome Using Abbott's Sensitive Troponin Assay |
18-May-2011 |
| Abbott Receives FDA Approval for Molecular Test for Hepatitis C |
18-May-2011 |
| Abbott's HUMIRA® (Adalimumab) Meets Primary Endpoints in Phase III Ulcerative Colitis Study |
10-May-2011 |
| Abbott's New FreeStyle InsuLinx Blood Glucose Monitoring System with Insulin Calculator Receives CE Mark |
10-May-2011 |
| Abbott Receives FDA Approval to Expand Use of the RX ACCULINK® Carotid Stent System to Patients at Standard Surgical Risk |
6-May-2011 |
| Abbott to Present at Bank of America Merrill Lynch 2011 Health Care Conference |
3-May-2011 |
| Abbott Receives U.S. FDA Approval for AndroGel(R) 1.62% to Treat Men with Low Testosterone |
29-Apr-2011 |
| Abbott Highlights Top-Tier Financial Performance, Strong Growth in Emerging Markets at Annual Meeting |
29-Apr-2011 |
| Abbott Reports 17.4 Percent Sales Growth and 12.3 Percent Ongoing Earnings-Per-Share Growth in First Quarter |
20-Apr-2011 |
| Abbott Chairman and CEO Miles D. White Elected to the American Academy of Arts & Sciences |
19-Apr-2011 |
| New Fully Automated Vitamin D Assay Submitted for FDA Clearance |
15-Apr-2011 |
| Data From Landmark Clinical Trial of Abbott's MitraClip(R) System Demonstrate Durable Clinical Benefits for Patients With Mitral Regurgitation Two Years After Treatment |
4-Apr-2011 |
| Abbott and Enanta Present Positive 12-Week Results and 3-Day Resistance Data From Phase 2 Study of ABT-450/r for Treatment of Hepatitis C |
4-Apr-2011 |
| Abbott's ABSORB Bioresorbable Vascular Scaffold Demonstrates Positive One-Year Safety and Efficacy Results |
3-Apr-2011 |
| Analysis of Data Across Multiple Drug Eluting Stent Trials Reinforces Positive Clinical Performance of XIENCE V(R) |
3-Apr-2011 |
| Abbott Hosts Conference Call for First-Quarter Earnings |
31-Mar-2011 |
| Abbott Announces Launch of Catheter-Based MitraClip(R) System in Australia for Mitral Regurgitation, the Most Common Heart Valve Condition |
30-Mar-2011 |
| FDA Clears Abbott's i-STAT(R) 1 Wireless Point of Care Testing System |
29-Mar-2011 |
| Abbott Introduces Micro-Implantation Cataract Suite |
28-Mar-2011 |
| Abbott to Present Data on Novel Vascular Technologies and XIENCE V(R) at ACC 2011 |
28-Mar-2011 |
| Abbott Supports Relief Efforts in Japan |
14-Mar-2011 |
| Positive Results from Phase 2 Study of Atrasentan for Treatment of Diabetic Kidney Disease Published in the Journal of the American Society of Nephrology |
4-Mar-2011 |
| Abbott to Present at Barclays Capital 2011 Global Healthcare Conference |
1-Mar-2011 |
| Abbott to Present at Cowen and Company 31st Annual Health Care Conference |
22-Feb-2011 |
| Abbott Announces Increase in Quarterly Dividend |
18-Feb-2011 |
| Abbott to Present at RBC Capital Markets' Healthcare Conference |
15-Feb-2011 |
| Abbott's Ibis Technology Identified Fatal Disease Organism in Afghanistan |
7-Feb-2011 |
| Abbott Introduces Biothreat Assay for PLEX-ID(TM) System |
7-Feb-2011 |
| Abbott's TREK(R) Coronary Balloon System Now Available in the United States and Japan |
31-Jan-2011 |
| FDA Advisory Committee Votes Favorably on Expanding the Indication for Abbott's Carotid Stent System to Include Patients at Standard Surgical Risk |
26-Jan-2011 |
| Abbott Reports Double-Digit Sales and Ongoing Earnings Growth in Fourth Quarter; Issues Strong Ongoing Earnings Outlook for 2011 |
26-Jan-2011 |
| Abbott Receives CE Mark Approval for World's First Drug Eluting Bioresorbable Vascular Scaffold for Treatment of Coronary Artery Disease |
10-Jan-2011 |
| Partners In Health, Abbott and the Abbott Fund Unite to Combat Severe Childhood Malnutrition in Haiti |
7-Jan-2011 |
| Abbott Hosts Conference Call for Fourth-Quarter and Full-Year 2010 Earnings |
3-Jan-2011 |
| Abbott and AstraZeneca End License Agreement for the Development of CERTRIAD(TM) |
22-Dec-2010 |
| Abbott Diabetes Care Announces Recall of Certain Lots of Precision Xtra(R), Precision Xceed Pro(R), MediSense(R) Optium(TM), Optium(TM), OptiumEZ and ReliOn(R) Ultima Blood Glucose Test Strips in the United States and Puerto Rico |
22-Dec-2010 |
| Abbott to Present at J.P. Morgan Healthcare Conference |
22-Dec-2010 |
| EpiTherapeutics and Abbott Enter Into Oncology Collaboration on Epigenetic Targets |
20-Dec-2010 |
| Abbott Declares 348th Consecutive Quarterly Dividend |
10-Dec-2010 |
| Abbott Again Recognized for Leadership in Workplace Diversity and Inclusion |
23-Nov-2010 |
| Abbott Announces Positive Results from Phase 2 Study of Low Dose Atrasentan for Treatment of Diabetic Kidney Disease |
22-Nov-2010 |
| Reata and Abbott Announce Positive Phase 2b Study Results for Bardoxolone Methyl |
20-Nov-2010 |
| Abbott Named One of America's Most Generous Companies, Sets Company Records for Employee Giving |
16-Nov-2010 |
| Abbott Awards Scholarships to Students Living with Cystic Fibrosis to Help Them Pursue Their Dreams |
11-Nov-2010 |
| Abbott Remains on the Dow Jones Sustainability Indexes for the Sixth Consecutive Year in Recognition of Leading Corporate Citizenship Performance |
8-Nov-2010 |
| Abbott Joins Clinton Health Access Initiative in Effort to Improve Infant Testing for HIV in Africa |
8-Nov-2010 |
| Abbott Presents Data Exploring Relationship of Physical Function to Inflammation and Structural Damage in RA |
8-Nov-2010 |
| Abbott Wins Two Scrip Awards Recognizing Excellence in Pharmaceutical and Biotech Industries |
5-Nov-2010 |
| ARCHITECT HIV Ag/Ab Combo Test Wins Prestigious Chicago Innovation Award |
3-Nov-2010 |
| Abbott to Present at 2010 Credit Suisse Annual Health Care Conference |
2-Nov-2010 |
| Abbott and Enanta Present Positive Initial Results from Phase 2 Study of ABT-450/r for Treatment of Hepatitis C |
1-Nov-2010 |
| Abbott Again Recognized for Environmental Initiatives in Illinois |
28-Oct-2010 |
| Abbott Statement: Abbott Provides Support for Cholera Relief Efforts in Haiti |
27-Oct-2010 |
| Abbott's New ZonePerfect(R) Cookie Dough Nutrition Bars: A Nutritious Twist for Cookie Dough Lovers |
27-Oct-2010 |
| Abbott Reports Strong Third Quarter Results; Confirms Double-Digit Ongoing Earnings Outlook for 2010 |
20-Oct-2010 |
| Abbott Reports Psoriasis Phase III Results of its Investigational IL-12/23 Inhibitor Briakinumab (ABT-874) |
11-Oct-2010 |
| Abbott to Voluntarily Withdraw Meridia(R) (Sibutramine) in the U.S. |
8-Oct-2010 |
| Abbott Named One of the 'Top Employers' in the Biotech and Pharmaceutical Industry by Science Magazine |
7-Oct-2010 |
| Abbott Receives FDA Market Clearance for Next-Generation Contact Lens Disinfecting Solution |
29-Sep-2010 |
| Abbott Hosts Conference Call for Third-Quarter Earnings |
29-Sep-2010 |
| Abbott Posts Lot Numbers for Recalled Similac(R) Brand Powder Infant Formulas |
23-Sep-2010 |
| Abbott's XIENCE V(R) Shows Continued Strong Performance in Key Safety and Efficacy Measures at Two Years in Investigator-Initiated COMPARE Trial |
23-Sep-2010 |
| Abbott's XIENCE V(R) Shows Outstanding Two-Year Clinical Results Versus TAXUS(R) in Key Safety and Efficacy Measures in SPIRIT IV Trial |
23-Sep-2010 |
| Abbott and Reata Pharmaceuticals Announce Agreement to Develop and Commercialize Bardoxolone Methyl for Chronic Kidney Disease Outside the U.S. |
23-Sep-2010 |
| Abbott's Fully Bioresorbable Vascular Scaffold Technology Continues to Demonstrate Strong Clinical Results |
22-Sep-2010 |
| Abbott Voluntarily Recalls Certain Similac(R) Brand Powder Infant Formulas That Did Not Meet Its Quality Standards |
22-Sep-2010 |
| The Deal Names Abbott Top Dealmaker for Third Consecutive Year |
20-Sep-2010 |
| Abbott Introduces Sports Nutrition Performance Beverage - EAS Peak(TM) With New P3(TM) Technology |
20-Sep-2010 |
| Abbott Declares 347th Consecutive Quarterly Dividend |
16-Sep-2010 |
| Abbott Launches New Ensure(R) Shakes with Focus on Helping Baby Boomers Regain Muscle and Strength |
16-Sep-2010 |
| Abbott to Present Data on Market-Leading XIENCE V(R) and Promising Vascular Pipeline at TCT 2010 |
16-Sep-2010 |
| Abbott Statement on the FDA Advisory Committee Recommendation on Sibutramine |
15-Sep-2010 |
| Abbott Honored for Workplace Leadership for the Tenth Consecutive Year by Working Mother Magazine |
14-Sep-2010 |
| Abbott Included on the Dow Jones Sustainability Indexes for Six Consecutive Years in Recognition of Leading Corporate Citizenship Performance |
9-Sep-2010 |
| Abbott Completes Acquisition of Piramal's Healthcare Solutions Business, Becomes Leading Pharmaceutical Company in India |
8-Sep-2010 |
| Abbott Receives FDA Approval for First Automated Molecular Test for Assessing Hepatitis B Treatment |
1-Sep-2010 |
| Abbott to Present at Morgan Stanley Global Healthcare Unplugged Conference |
30-Aug-2010 |
| Abbott Launches New Psoriasisanswers.com Web site |
12-Aug-2010 |
| Abbott's SIMCOR (R) ( niacin extended-release / simvastatin ) Receives FDA Approval for New Dosage Strengths |
28-Jul-2010 |
| Abbott Fund-Sponsored Laboratory Training Initiative Helps Stem Critical Shortage of Medical Professionals in California |
28-Jul-2010 |
| Abbott to Feature Novel Tests and New Upgrades to Testing Platforms at American Association for Clinical Chemistry Lab Expo |
26-Jul-2010 |
| Abbott to Present at Wedbush Securities Life Sciences Best Ideas MAC Conference |
22-Jul-2010 |
| Abbott Reports Strong Second Quarter Results; Confirms Double-Digit Ongoing Earnings Growth Outlook for 2010 |
21-Jul-2010 |
| Abbott's PROGRESS Study of Kaletra and Isentress Compared with a Standard HIV Regimen Meets the Pre-Specified Primary Efficacy Endpoint |
19-Jul-2010 |
| Abbott Hosts Conference Call for Second-Quarter Earnings |
7-Jul-2010 |
| Abbott Receives FDA Clearance for Molecular Diagnostic Test for Detection of Chlamydia and Gonorrhea Infections |
28-Jun-2010 |
| Abbott Receives FDA Clearance for New, Easier-to-Use FreeStyle(R) Test Strips |
24-Jun-2010 |
| FDA Approves First-of-Its-Kind HIV Test Which Can Detect HIV Days Earlier Than Current U.S. Tests |
21-Jun-2010 |
| Abbott and Neurocrine Announce Global Agreement to Develop and Commercialize Elagolix for the Treatment of Endometriosis |
16-Jun-2010 |
| Abbott Declares 346th Consecutive Quarterly Dividend |
11-Jun-2010 |
| Despite Risks, Americans Are Not Taking Action to Protect Themselves Against Muscle Loss as They Age |
9-Jun-2010 |
| Abbott to Present Data on Several Investigational Cancer Treatments at American Society of Clinical Oncology Annual Meeting |
3-Jun-2010 |
| Abbott Receives FDA Clearance for New Ovarian Cancer Test |
3-Jun-2010 |
| Abbott to Present at Goldman Sachs 31st Annual Global Healthcare Conference |
3-Jun-2010 |
| The New England Journal of Medicine Publishes Results of Landmark CREST Study, Showing Similar Positive Outcomes for Abbott's Carotid Stent System and Surgery |
26-May-2010 |
| Abbott Announces European Launch of TREK(TM) Catheter System, Representing an Advancement in Balloon Technology |
26-May-2010 |
| Abbott's Groundbreaking Bioresorbable Technology Continues to Demonstrate Exceptional Clinical Results |
25-May-2010 |
| New Data Reinforces Safety Profile of Abbott's Market-Leading XIENCE V(R) Drug Eluting Stent |
25-May-2010 |
| Abbott's Investigational MitraClip(R) System Demonstrates Strong Safety Results and Improved Clinical Outcomes for Common Causes of Leaky Heart Valves |
25-May-2010 |
| Abbott Receives FDA Clearance for New, Easier-to-Use FreeStyle Lite(R) Test Strips |
24-May-2010 |
| Abbott to Become No. 1 Pharmaceutical Company in India with Acquisition of Piramal's Healthcare Solutions Business |
21-May-2010 |
| Abbott to Present New Clinical Data on Current and Future Innovations in Interventional Cardiology at EuroPCR 2010 |
20-May-2010 |
| Abbott Honored as a Great Place to Work Across Europe |
20-May-2010 |
| Abbott Receives FDA Approval for First Fully Automated Blood Test for 'Kissing Bug' Disease |
19-May-2010 |
| Abbott Presents Do-It-Yourself Home Makeover Tips for Arthritis Awareness Month |
13-May-2010 |
| Abbott Accelerates Emerging Markets Pharmaceutical Leadership With Zydus Cadila Collaboration; Separately Creates Stand-Alone Established Products Division |
11-May-2010 |
| Abbott 2009 Global Citizenship Report Highlights Company's Progress in 'Redefining Responsibility' |
6-May-2010 |
| The New England Journal of Medicine Publication of SPIRIT IV Trial Results Confirm Superior Safety and Efficacy of Abbott's XIENCE V(R) Drug Eluting Stent Compared to TAXUS |
5-May-2010 |
| Abbott Chairman and CEO Miles D. White to Present at Sanford Bernstein Strategic Decisions Conference |
5-May-2010 |
| Abbott Opens Asia-Pacific Nutrition Research & Development Center in Singapore |
5-May-2010 |
| Abbott Receives FDA Approval for CREON(R) to Include Dosing Information for Patients With Chronic Pancreatitis and Pancreatectomy |
3-May-2010 |
| Abbott Receives FDA Approval for Once-Daily Dosing of Kaletra (R) (lopinavir / ritonavir) for Treatment-Experienced Patients |
28-Apr-2010 |
| Abbott Recognized as One of the 'Best Places to Work in Industry' by The Scientist magazine |
28-Apr-2010 |
| Despite Concern, Americans Aren't Protecting Themselves Against Diabetes |
28-Apr-2010 |
| Abbott Annual Meeting Highlights Continued Strong Performance in 2009; Sustained Growth in 2010 |
23-Apr-2010 |
| Abbott Completes Acquisition of Facet Biotech |
21-Apr-2010 |
| Abbott Reports Strong First Quarter Results; Forecasts Double-Digit Ongoing Earnings Growth in 2010 |
21-Apr-2010 |
| Abbott Successfully Completes Tender Offer for Shares of Facet Biotech |
20-Apr-2010 |
| Abbott Begins Biopreparedness Evaluation Program With State Public Health Labs |
15-Apr-2010 |
| Abbott Acquisition of Facet Biotech Clears U.S. Antitrust Review |
8-Apr-2010 |
| Abbott Submits Test to Aid in Identifying Patients at Risk of Developing Kidney Injury |
31-Mar-2010 |
| Abbott Hosts Conference Call for First-Quarter Earnings |
31-Mar-2010 |
| AstraZeneca and Abbott Receive FDA Complete Response Letter on CERTRIAD(TM) New Drug Application |
30-Mar-2010 |
| Abbott Commences Tender Offer for All Outstanding Shares of Facet Biotech Corporation |
23-Mar-2010 |
| Abbott Completes Acquisition of STARLIMS Technologies |
22-Mar-2010 |
| The Abbott Fund, Boston University School of Medicine and Leading Health Institutions in Vietnam Inaugurate the Abbott Fund Institute of Nutrition Science at Bach Mai Hospital |
19-Mar-2010 |
| Abbott Announces Positive Data From ABSORB Trial on Its Bioresorbable Vascular Scaffold Technology |
15-Mar-2010 |
| New Data Demonstrates Abbott's Investigational MitraClip(R) System Has Potential to be a Valuable Treatment Option for Patients With Mitral Regurgitation, the Most Common Heart Valve Condition |
14-Mar-2010 |
| Abbott Statement: ACCORD Lipid Results Support Treatment Guidelines for Fibrate Use |
14-Mar-2010 |
| Abbott Seeks FDA Approval of a New Six-Month 45-mg Formulation of Lupron(R) Depot for the Palliative Treatment of Advanced Prostate Cancer |
11-Mar-2010 |
| Abbott Receives U.S. FDA Approval for New Cataract Multifocal Intraocular Lens |
10-Mar-2010 |
| Abbott Enhances Pharmaceutical Pipeline with Acquisition of Facet Biotech |
9-Mar-2010 |
| Abbott to Collaborate With GSK on Molecular Diagnostic Test to Select Candidate Patients for Future Skin Cancer Immunotherapy |
3-Mar-2010 |
| Abbott and Enanta Announce Advancement of Hepatitis C Collaboration |
2-Mar-2010 |
| Twenty-Five Years of HIV Blood Testing Helped to Positively Transform Global Health Crisis |
2-Mar-2010 |
| Abbott to Present at Cowen and Company Annual Health Care Conference |
24-Feb-2010 |
| Abbott Announces 10 Percent Increase in Quarterly Dividend |
19-Feb-2010 |
| Abbott Completes Acquisition of Solvay Pharmaceuticals |
16-Feb-2010 |
| Abbott Receives U.S. FDA Approval for Heat-Stable Norvir(R) (ritonavir) Tablets |
11-Feb-2010 |
| Abbott Submits New Automated Ovarian Cancer Test for U.S. Approval |
8-Feb-2010 |
| Abbott and Pierre Fabre SA Announce Collaboration to Research and Develop Novel Treatments for Cancer |
1-Feb-2010 |
| Abbott Reports Double-Digit Sales and Earnings Growth in Fourth Quarter; Issues Strong Earnings Outlook for 2010 |
27-Jan-2010 |
| Abbott Submits New HIV Test to FDA for Expedited Review |
25-Jan-2010 |
| Updated Abbott Statement: To Help Respond to Growing Health Crisis, Abbott Increases Aid to $2.5 Million for Haiti Relief and Recovery Efforts |
18-Jan-2010 |
| Abbott Receives European Regulatory Approval for New Ovarian Cancer Diagnostic Test |
14-Jan-2010 |
| Abbott to Provide $1 Million in Funding, Products to Help Address Health Needs in Haiti |
13-Jan-2010 |
| Abbott's XIENCE V(R) Approved in Japan - Second Largest Drug Eluting Stent Market Worldwide |
8-Jan-2010 |
| Abbott to Present at J.P. Morgan Healthcare Conference |
4-Jan-2010 |
| Abbott Hosts Conference Call for Fourth-Quarter and Full-Year 2009 Earnings |
4-Jan-2010 |
| Abbott to Acquire STARLIMS Technologies Ltd., a Leader in Laboratory Information Management Systems |
14-Dec-2009 |
| Abbott Declares 344th Consecutive Quarterly Dividend |
11-Dec-2009 |
| Abbott and the Abbott Fund Honored With Corporate Citizenship Award for International Community Service |
2-Dec-2009 |
| Abbott's Ibis Technology Named One of the Top Innovations for 2009 by The Scientist |
2-Dec-2009 |
| The Deal Names Abbott Top Dealmaker for Second Consecutive Year |
19-Nov-2009 |
| Abbott to Develop New Heart Failure Test on ARCHITECT(R) Immunochemistry Diagnostics Platform |
17-Nov-2009 |
| Abbott Announces Positive Three-Year Data on Its Fully Bioabsorbable Stent Technology, Initiates Large-Scale International Trial |
16-Nov-2009 |
| Abbott Statement on ARBITER 6 - HALTS Results and Abbott's Niaspan (niacin extended-release) |
15-Nov-2009 |
| New Web Sites Educate About Triglycerides and HDL Cholesterol |
12-Nov-2009 |
| Abbott to Acquire Novel Investigational Biologic to Treat Chronic Pain |
12-Nov-2009 |
| President of Tanzania and the Abbott Fund Dedicate Modern Emergency Medical Department |
3-Nov-2009 |
| Abbott Saving 1 Billion Gallons of Water Annually |
2-Nov-2009 |
| Abbott Completes Acquisition of Evalve, Inc. |
2-Nov-2009 |
| Abbott Receives Sustainability Award for Continued Efforts to Protect the Environment in Illinois |
29-Oct-2009 |
| Abbott Opens New R&D Center at University of Illinois Research Park |
22-Oct-2009 |
| Abbott Completes Visiogen Acquisition |
20-Oct-2009 |
| FDA Approves New Test to Aid in the Diagnosis of Rheumatoid Arthritis |
20-Oct-2009 |
| Photo: ZonePerfect Indulgence(TM) Nutrition Squares Give Chocolate Lovers a Sensible Sweet-Tooth Option |
19-Oct-2009 |
| Abbott Reports 16.5 Percent Earnings Growth in Third Quarter; Raises Earnings Guidance for 2009 |
14-Oct-2009 |
| Abbott Cuts Use of Oil and Coal by 35 Percent |
30-Sep-2009 |
| Abbott to Acquire Solvay Pharmaceuticals Business |
28-Sep-2009 |
| Results from Abbott's PROSPECT Study Provide New Insight into Role of Vulnerable Plaque in Coronary Artery Disease |
24-Sep-2009 |
| Abbott Hosts Conference Call for Third-Quarter Earnings |
24-Sep-2009 |
| Abbott's XIENCE V(R) Demonstrates Significantly Lower Rates of MACE and Stent Thrombosis Compared to TAXUS(R) Liberte in Investigator-Initiated COMPARE Trial |
23-Sep-2009 |
| Abbott's XIENCE V® Superior to TAXUS® in Key Safety and Efficacy Measures in SPIRIT IV Trial |
23-Sep-2009 |
| Abbott Again Honored for Offering One of the 'Top 10' Leading Workplaces |
22-Sep-2009 |
| Abbott's XIENCE V(R) Continues to Outperform TAXUS With Sustained Clinical Advantages and Impressive Long-Term Safety Results in SPIRIT III Trial |
21-Sep-2009 |
| Abbott Receives FDA Approval for First Fully Automated Blood Screening Test for HIV-1/HIV-2 |
21-Sep-2009 |
| Abbott Declares 343rd Consecutive Quarterly Dividend |
17-Sep-2009 |
| Abbott Announces TCT 2009 Activities |
16-Sep-2009 |
| Abbott Expands Use of Sustainable Packaging as Part of Global Environmental Efforts |
16-Sep-2009 |
| Abbott Wins Top Honor in Wall Street Journal Technology Innovation Awards |
15-Sep-2009 |
| Abbott Announces Approval in China for Next-Generation XIENCE V(R) Drug Eluting Stent |
14-Sep-2009 |
| Abbott to Acquire Evalve, Inc., a Leader in Minimally Invasive Cardiac Valve Repair Technology |
10-Sep-2009 |
| Abbott Again Named One of the 'Best Places to Launch a Career' by BusinessWeek |
4-Sep-2009 |
| Abbott Listed on Dow Jones Sustainability Indexes For Fifth Consecutive Year |
3-Sep-2009 |
| Abbott to Acquire Visiogen, Expanding Vision Care Portfolio |
2-Sep-2009 |
| Abbott to Present at Morgan Stanley Global Healthcare Unplugged Conference |
31-Aug-2009 |
| Abbott Launches Next-Generation XIENCE PRIME(TM) Drug Eluting Stent in International Markets |
31-Aug-2009 |
| Abbott to Collaborate With Pfizer Inc on Companion Diagnostic Test to Select Patient Candidates for Novel Investigational Non-Small Cell Lung Cancer Therapy |
27-Aug-2009 |
| Health Canada Approves Abbott's XIENCE V(R) Drug Eluting Stent |
24-Aug-2009 |
| Abbott Announces Partnership with Velcera to Bring New Pain Medication for Dogs to Market |
18-Aug-2009 |
| Abbott Expands XIENCE V(R) USA Trial to Enroll Patients into Landmark Dual Anti-Platelet Therapy (DAPT) Trial |
13-Aug-2009 |
| Abbott Testifies Before U.S. Congress on Role of Private Sector in Advancing Science Education |
30-Jul-2009 |
| Abbott to Acquire Nutrition Businesses, Expanding Presence in India |
28-Jul-2009 |
| Abbott and Medtronic Reach Agreement on Global Patent Disputes |
27-Jul-2009 |
| Labs Are Vital(TM) Announces Winners of 2009 National Video Contest to Highlight Careers in Lab Sciences |
21-Jul-2009 |
| Abbott Introduces Molecular Diagnostic System Intended for Broad Identification of Infectious Agents |
21-Jul-2009 |
| Abbott Launches New Instrument to Complete Family of ARCHITECT Immunochemistry Analyzers |
21-Jul-2009 |
| Abbott Reports Strong Second Quarter Results; Confirms Double-Digit Earnings Growth Outlook for 2009 |
15-Jul-2009 |
| Abbott and GSK to Collaborate on Molecular Diagnostic Test to Select Candidate Patients for Future Cancer Immunotherapy |
13-Jul-2009 |
| Abbott and Oasmia Pharmaceutical Announce Exclusive Distribution Agreement for Paccal(R) Vet, a New Chemotherapeutic Agent for Dogs |
10-Jul-2009 |
| Abbott Hosts Conference Call for Second-Quarter Earnings |
24-Jun-2009 |
| Abbott Receives CE Mark for Company's Next-Generation XIENCE PRIME(TM) Drug Eluting Stent, Advancing Leadership Position |
23-Jun-2009 |
| Abbott Initiates Trial of Next-Generation XIENCE PRIME(TM) Drug Eluting Stent, Building Upon Superior Outcomes from SPIRIT Family of Trials |
16-Jun-2009 |
| Abbott Declares 342nd Consecutive Quarterly Dividend |
12-Jun-2009 |
| Abbott Announces Launch of Next-Generation Embolic Protection System |
12-Jun-2009 |
| Abbott Announces New EAS(R) Myoplex(R) Strength Formula Nutrition Shake and Debuts Bottle Packaging |
9-Jun-2009 |
| Abbott's TRILIPIX(R) (Fenofibric Acid) in Combination With Rosuvastatin Calcium Helps Patients With Mixed Dyslipidemia and Type 2 Diabetes Meet American Diabetes Association Lipid Targets |
8-Jun-2009 |
| Three New ZonePerfect(R) Dark Chocolate Nutrition Bar Flavors Fuel Satisfying and Delicious Snacking |
2-Jun-2009 |
| Abbott to Present at Goldman Sachs Global Healthcare Conference |
1-Jun-2009 |
| Abbott Named One of the Top 10 Companies for Scientists |
29-May-2009 |
| Abbott's XIENCE V(R) Demonstrates Impressive Low Rates of Repeat Procedure, Stent Thrombosis and Major Adverse Cardiac Events in Complex, 'Real World' Patients in SPIRIT V Study |
21-May-2009 |
| Abbott Announces EuroPCR 2009 Activities |
18-May-2009 |
| HIV/AIDS Research Network Recommends Use of Abbott RealTime Viral Load Test for NIH-Sponsored Clinical Trials |
7-May-2009 |
| Abbott Highlights Strong Corporate Responsibility Performance With Release of 2008 Global Citizenship Report |
27-Apr-2009 |
| Abbott Annual Meeting Highlights Outstanding 2008 Results, Continued Strong Outlook |
24-Apr-2009 |
| Abbott Initiates U.S. Study of Absolute Pro(TM) Peripheral Stent System for Iliac Artery Disease |
1-Apr-2009 |
| New Data for Abbott's TRILIPIX(R) (fenofibric acid) in Combination with Rosuvastatin Calcium Shows Improvement on Key Lipids for Cholesterol Management |
29-Mar-2009 |
| Abbott's Market-Leading XIENCE V(R) Shows Increasing Clinical Advantages Over TAXUS(R) Express2(TM)/TAXUS(R) Liberte(TM) Between Two and Three Years |
29-Mar-2009 |
| Abbott Hosts Conference Call for First-Quarter Earnings |
25-Mar-2009 |
| Abbott Advances Its Revolutionary Fully Bioabsorbable Drug Eluting Stent With Initiation of Next Phase of Clinical Trial |
24-Mar-2009 |
| Photo: ZonePerfect(R) Nutrition Bars Launches Nationwide Tour With VH1 Save The Music Foundation to Nourish Arts, America's Schools |
19-Mar-2009 |
| The Lancet Publishes Two-Year Results of Abbott's Fully Bioabsorbable Drug Eluting Stent |
12-Mar-2009 |
| Abbott Launches VOYAGER(TM) NC Coronary Balloon Catheter |
10-Mar-2009 |
| Abbott to Present at Cowen Annual Health Care Conference |
4-Mar-2009 |
| Abbott Announces Required Offer to Repurchase Convertible Senior Subordinated Notes of Its AMO Subsidiary |
27-Feb-2009 |
| Abbott Completes Acquisition of Advanced Medical Optics |
26-Feb-2009 |
| Abbott Opens New Pediatric Nutrition Manufacturing Facility in Singapore |
25-Feb-2009 |
| Abbott Successfully Completes Tender Offer for Shares of Advanced Medical Optics |
25-Feb-2009 |
| Abbott to Present at Barclays Global Healthcare Conference |
24-Feb-2009 |
| Abbott Employee Giving Sets New Records for Employee Participation and Total Donations |
23-Feb-2009 |
| Abbott Receives European Commission Clearance on Acquisition of Advanced Medical Optics |
20-Feb-2009 |
| Abbott Announces 11 Percent Increase in Quarterly Dividend |
20-Feb-2009 |
| Abbott Nutrition Announces Voluntary Recall of ZonePerfect(R) Chocolate Caramel Cluster Bars, Champions(TM) Chocolate Peanut Butter Bars and Glucerna(R) Chocolate Peanut Bars |
16-Feb-2009 |
| Abbott Receives FDA Clearance for New CELL-DYN(R) Emerald(TM) Hematology Instrument |
11-Feb-2009 |
| Increasing Diversity of HIV Strains Impacts Diagnostic Test Accuracy |
10-Feb-2009 |
| Data Suggests New Antigen-Antibody Combo Test Useful for High Volume Public Health Screening |
9-Feb-2009 |
| Abbott Acquisition of Advanced Medical Optics Clears U.S. Antitrust Review |
6-Feb-2009 |
| Circulation Publishes Pivotal Two-Year Results On XIENCE V(TM) Drug Eluting Stent |
26-Jan-2009 |
| Abbott to Commence Tender Offer on Jan. 27 for All Outstanding Shares of Advanced Medical Optics, Inc. |
26-Jan-2009 |
| Abbott Opens New Pharmaceutical Research Laboratory in Singapore |
20-Jan-2009 |
| Abbott Nutrition Announces Voluntary Recall of ZonePerfect(R) Chocolate Peanut Butter Bars, ZonePerfect(R) Peanut Toffee Bars and NutriPals(TM) Peanut Butter Chocolate Bars in U.S., Mexico, New Zealand and Singapore |
19-Jan-2009 |
| Abbott Receives FDA CLIA Waiver for Use of Five Additional Cartridges on the i-STAT Handheld Blood Analyzer |
19-Jan-2009 |
| Abbott Announces Earnings Guidance for 2009 |
12-Jan-2009 |
| Abbott Expands Its Growing Medical Device Business With Acquisition of Advanced Medical Optics (AMO) |
12-Jan-2009 |
| Abbott Hosts Conference Call for Fourth-Quarter and Full-Year 2008 Earnings |
18-Dec-2008 |
| Abbott Begins U.S. Study of XIENCE V(TM) Drug Eluting Stent Designed for Small Vessels |
17-Dec-2008 |
| Abbott to Present at J.P. Morgan Healthcare Conference |
16-Dec-2008 |
| (Multimedia Version): Abbott Receives FDA Approval for TRILIPIX(TM) (fenofibric acid), First and Only Fibrate Indicated for Use in Combination With a Statin for Cholesterol Management |
15-Dec-2008 |
| Abbott Receives FDA Approval for TRILIPIX(TM) (fenofibric acid), First and Only Fibrate Indicated for Use in Combination With a Statin for Cholesterol Management |
15-Dec-2008 |
| Abbott Declares 340th Consecutive Quarterly Dividend |
12-Dec-2008 |
| Abbott Honored as One of The Deal's Most Admired Corporate Dealmakers |
12-Nov-2008 |
| Abbott to Present at 17th Annual Credit Suisse Health Care Conference |
29-Oct-2008 |
| Abbott's XIENCE V(TM) Drug Eluting Stent Wins Prestigious Chicago Innovation Award |
28-Oct-2008 |
| Abbott Receives Complete Response Letter From FDA for Controlled-Release Hydrocodone With Acetaminophen |
20-Oct-2008 |
| Abbott's XIENCE V(TM) Drug Eluting Stent Outperforms TAXUS(R) in Key Efficacy and Safety Endpoints Out to Two Years |
13-Oct-2008 |
| Abbott Announces New $5 Billion Share Repurchase Program |
13-Oct-2008 |
| New Data Shows Abbott's Bioabsorbable Drug Eluting Stent is Absorbed Within Two Years - Leaving Behind Functioning Blood Vessels |
13-Oct-2008 |
| Abbott Opens New Research Facility and Pilot Plant in Ludwigshafen |
9-Oct-2008 |
| Creator of Glucose Measurement Technology Used In Abbott's Diabetes Care Products Receives National Medal of Technology and Innovation |
29-Sep-2008 |
| Abbott Named One of the 'Top 10' Innovative Family-Friendly Companies by Working Mother Magazine |
23-Sep-2008 |
| Abbott Hosts Conference Call for Third-Quarter Earnings |
19-Sep-2008 |
| Continuous Treatment With Abbott's HUMIRA(R) Achieves Superior Long-Term Efficacy for Psoriasis Patients Compared to Interrupting Treatment |
18-Sep-2008 |
| Abbott Declares 339th Consecutive Quarterly Dividend |
12-Sep-2008 |
| Abbott to Present at Bank of America 38th Annual Investment Conference |
5-Sep-2008 |
| Abbott to Present at UBS 'Best of Americas' Investment Conference |
5-Sep-2008 |
| Abbott Recognized on Dow Jones Sustainability Index (DJSI) for Fourth Consecutive Year |
4-Sep-2008 |
| Abbott Fund to Build First Pediatric HIV/AIDS Clinic in Tanzania |
29-Aug-2008 |
| Patient Side Point-of-Care Testing in the Emergency Department Enables Quicker Treatment Decisions for Patients With Chest Pain |
19-Aug-2008 |
| Abbott and AstraZeneca Expand Relationship to Include Co-Promotion of CRESTOR(R) |
14-Aug-2008 |
| Abbott Study Shows Investigational Heat-Stable Norvir(R) Tablet Provides Similar Drug Levels to Current Norvir Capsule |
7-Aug-2008 |
| New Podcast Series From Abbott for People Living With Crohn's Disease |
6-Aug-2008 |
| Abbott's Kaletra(R) Tablet Dosed Once-Daily or Twice-Daily Demonstrated Similar Clinical Results Across Race and Gender Lines |
5-Aug-2008 |
| Abbott Donates Diagnostic Instruments As Part of the 'Labs Are Vital(TM)' Initiative |
30-Jul-2008 |
| Precise Low-Dose Drug Monitoring Essential for Long-Term Kidney Transplant Success |
30-Jul-2008 |
| Novel Diagnostic Marker for Acute Kidney Injury Previewed at Abbott-Sponsored Scientific Workshop |
29-Jul-2008 |
| Abbott Fund and the Government of Tanzania Celebrate Milestone in Strengthening Nation's Health Care System |
28-Jul-2008 |
| Abbott to Preview New CELL-DYN(R) Emerald(TM) Hematology Instrument |
28-Jul-2008 |
| Abbott To Unveil New ARCHITECT(R) ci4100(TM) Integrated Immunoassay and Clinical Chemistry System |
28-Jul-2008 |
| Abbott Begins Post-Approval Study of XIENCE V(TM) Drug Eluting Stent |
9-Jul-2008 |
| FDA Approves Abbott's XIENCE(TM) V Drug Eluting Stent |
2-Jul-2008 |
| Abbott Hosts Conference Call for Second-Quarter Earnings |
30-Jun-2008 |
| Earvin 'Magic' Johnson and Abbott Bring 'I Stand with Magic' Program: Part of the Campaign to End Black HIV/AIDS to Facebook Community |
27-Jun-2008 |
| Abbott and Partnership for a Drug-Free America Launch 'Not In My House' to Help Parents Secure Their Homes from Teen Prescription Drug Misuse and Abuse |
24-Jun-2008 |
| HUMIRA(R) (adalimumab) Data Show That Treating Early Rheumatoid Arthritis With Combination Treatment Resulted in Cost Savings From Improved Work Productivity |
13-Jun-2008 |
| Data Show that Abbott's HUMIRA(R) (adalimumab) Reduced the Signs and Symptoms of Ankylosing Spondylitis Up to Three Years |
13-Jun-2008 |
| New Long-Term HUMIRA(R) (adalimumab) Data Show Up to Seven-Year Efficacy with Combination Treatment for Rheumatoid Arthritis |
13-Jun-2008 |
| Abbott Opens New State-of-the-Art R&D Facility to Help Bring Medicines to Patients Faster |
12-Jun-2008 |
| Now Playing: Spike Lee Stands with Earvin 'Magic' Johnson, Cookie Johnson and Abbott to Launch National PSA Campaign |
9-Jun-2008 |
| Abbott's Phase III Sub-Group Analysis Shows Investigational TriLipix(TM) in Combination with CRESTOR(R) Improves Key Lipids in Patients with Mixed Dyslipidemia and Type 2 Diabetes |
7-Jun-2008 |
| Abbott Declares 338th Consecutive Quarterly Dividend |
6-Jun-2008 |
| American Diabetes Association Receives $450,000 Grant From Abbott Fund for Latino Community Initiatives |
2-Jun-2008 |
| Abbott Releases 2007 Global Citizenship Report Highlighting Strong Commitment to Access to Health Care |
2-Jun-2008 |
| Abbott Submits Application for Approval of XIENCE(TM) V Everolimus Eluting Coronary Stent System in Japan |
2-Jun-2008 |
| Phase III Study of Abbott's Investigational TriLipix(TM) in Combination With AstraZeneca's CRESTOR(R) Meets Primary Endpoints on Key Lipids |
31-May-2008 |
| Abbott to Present at Goldman Sachs Global Healthcare Conference |
28-May-2008 |
| Abbott Presents Long-Term Data From Extension Study Showing Adult Crohn's Patients Treated With HUMIRA(R) (Adalimumab) Maintained Remission |
21-May-2008 |
| ZonePerfect Dark Chocolate Nutrition Bars Indulge Chocoholics |
19-May-2008 |
| Abbott Launches Next-Generation StarClose(R) SE Vascular Closure System |
16-May-2008 |
| Abbott to Present Data on Novel Cancer Treatments at American Society of Clinical Oncology Annual Meeting |
15-May-2008 |
| XIENCE(TM) V Drug Eluting Stent from Abbott Outperforms Market-Leading Stent in Reducing Major Adverse Cardiac Events at Two Years |
13-May-2008 |
| New Abbott Study of Investigational Vicodin CR(TM) Meets Primary Efficacy Endpoints in Phase III Trial |
8-May-2008 |
| Abbott Scientists Present a New Approach for Treating Attention-Deficit Hyperactivity Disorder |
7-May-2008 |
| Abbott to Present at Citi Investment Research Global Health Care Conference |
7-May-2008 |
| Abbott, Takeda Conclude TAP Joint Venture |
1-May-2008 |
| Abbott Annual Meeting Highlights Outstanding 2007 Results, International Growth and Near-Term Pipeline |
25-Apr-2008 |
| Abbott Announces Labs Are Vital(TM) Facebook Scholarship Contest Winners |
24-Apr-2008 |
| Study in JAMA Shows Patients Treated With Abbott's XIENCE(TM) V Drug Eluting Stent Experience Better Outcomes Than Patients Treated With Market-Leading Drug Eluting Stent |
22-Apr-2008 |
| Abbott to Present at Morgan Stanley Global Healthcare Unplugged Conference |
22-Apr-2008 |
| Smiths Medical to Promote and Distribute Abbott's FreeStyle Navigator Continuous Glucose Monitoring System |
22-Apr-2008 |
| Abbott Announces HUMIRA(R) (adalimumab) Approved in Japan for the Treatment of Rheumatoid Arthritis |
16-Apr-2008 |
| Innovative Diagnostic Instrument Introduced by Abbott for Low- to Mid-Volume Laboratory Market Segment |
15-Apr-2008 |
| Abbott FreeStyle Freedom(R) Lite Blood Glucose Monitoring System Now Available With No Coding for People With Diabetes |
14-Apr-2008 |
| International Federation of Clinical Chemistry Forms Partnership With the Labs Are Vital(TM) Initiative |
4-Apr-2008 |
| Abbott's Phase III Studies of Investigational TriLipix(TM) (ABT-335), in Combination With Statins, Meets Primary Endpoints on Improving LDL, Triglycerides and HDL |
31-Mar-2008 |
| Abbott's XIENCE(TM) V Drug Eluting Stent Demonstrates Consistent and Positive Clinical Outcomes Out to Two Years |
31-Mar-2008 |
| The Lancet Publishes Results From World's First Clinical Trial of a Fully Bioabsorbable Drug Eluting Coronary Stent |
13-Mar-2008 |
| FDA Approves Abbott's FreeStyle Navigator(R) Continuous Glucose Monitoring System |
13-Mar-2008 |
| Abbott Receives CE Mark for Smaller-Size XIENCE(TM) V Drug Eluting Stent |
11-Mar-2008 |
| Abbott to Collaborate With Genentech, Roche and OSI on Molecular Test for Lung Cancer Therapy Response |
7-Mar-2008 |
| Abbott to Present at Lehman Brothers Healthcare Conference |
7-Mar-2008 |
| Abbott to Present at Cowen and Company Health Care Conference |
7-Mar-2008 |
| Labs are Vital(TM) Program Targets Science-Minded Students Through Facebook Social Media Network |
25-Feb-2008 |
| Abbott Receives FDA Approval for HUMIRA(R) (Adalimumab) for Polyarticular Juvenile Idiopathic Arthritis |
22-Feb-2008 |
| Abbott Receives FDA Approval for SIMCOR(R) (Niaspan(R) / simvastatin), a Novel Combination Medicine for Comprehensive Cholesterol Management |
15-Feb-2008 |
| Abbott Announces 10.8 Percent Increase in Quarterly Dividend |
15-Feb-2008 |
| On Valentine's Day, Abbott Urges Women to Take Heart With Launch of 'Faces of Heart Disease' Exhibit to Raise Heart Health Awareness |
13-Feb-2008 |
| Abbott 'Goes Red' to Educate Bay Area Women About Heart Disease |
1-Feb-2008 |
| Abbott 'Goes Red' to Educate Chicago-Area Women About Heart Disease |
1-Feb-2008 |
| Abbott to Present at Merrill Lynch Healthcare Conference |
29-Jan-2008 |
| Abbott's Kaletra(R) and Aluvia(R) (lopinavir/ritonavir) New Lower-Strength Tablet for Pediatric Use Receives Positive Opinion from EMEA |
28-Jan-2008 |
| Abbott's HUMIRA(R) (adalimumab) Receives FDA Approval For Moderate to Severe Chronic Plaque Psoriasis |
18-Jan-2008 |
| Abbott Announces Approval of First Fully Automated Blood Screening Test for HTLV-I/HTLV-II |
18-Jan-2008 |
| Abbott to Present at JP Morgan Healthcare Conference |
21-Dec-2007 |
| Abbott's HUMIRA(R) Approved in the European Union for Treatment of Moderate-to-Severe Plaque Psoriasis |
20-Dec-2007 |
| Abbott Declares 336th Consecutive Quarterly Dividend |
14-Dec-2007 |
| Abbott and HealthReach Increase Access to Health Care for Lake County's Uninsured With Newly Expanded Free Clinic |
12-Dec-2007 |
| Similac(R) Survey Finds New Moms Want Convenient, Time-Saving Baby Products |
11-Dec-2007 |
| Abbott Sets Aggressive Goal to Reduce Greenhouse Gas Emissions |
4-Dec-2007 |
| Cookie Johnson and Abbott Bring 'I Stand With Magic: Campaign to End Black AIDS' to Los Angeles to Educate African-American Women on HIV/AIDS |
1-Dec-2007 |
| Ugandan Children Are Among the First to Receive Abbott's Lower-Strength Aluvia (lopinavir/ritonavir) Tablet |
1-Dec-2007 |
| PHOTO ADVISORY -- The Magic Johnson Foundation and Abbott Expand Focus of 'Campaign to End Black AIDS' to African-American Women in 2008 |
30-Nov-2007 |
| The Magic Johnson Foundation and Abbott Expand Focus of 'Campaign to End Black AIDS' to African-American Women in 2008 |
30-Nov-2007 |
| FDA Advisory Committee Recommends Approval of Abbott's XIENCE(TM) V Drug Eluting Stent System |
29-Nov-2007 |
| Abbott to Present Comprehensive Safety and Efficacy Data on XIENCE(TM) V Drug Eluting Stent to FDA Advisory Committee on Nov. 29 |
27-Nov-2007 |
| Abbott's Environmental Protection Initiatives Again Recognized by the State of Illinois |
21-Nov-2007 |
| Abbott Employees Give Back to Local Communities This Holiday Season |
21-Nov-2007 |
| Abbott's HUMIRA(R) Receives Positive Opinion From EMEA for Treatment of Moderate to Severe Plaque Psoriasis |
16-Nov-2007 |
| Abbott Partners With Operation Smile to Support 40 Medical Missions in 25 Countries |
15-Nov-2007 |
| Abbott Receives U.S. Food and Drug Administration Approval for New Lower-Strength Kaletra(R) (lopinavir/ritonavir) Tablet for Pediatric HIV Patients |
12-Nov-2007 |
| Abbott Donates 'Cool Globe' to Lake County Forest Preserves for Permanent Display at Greenbelt Cultural Center |
9-Nov-2007 |
| Abbott Study Examines Rates of Uveitis (Inflammation of the Eye) in Ankylosing Spondylitis Patients Treated with HUMIRA(R) (adalimumab) |
8-Nov-2007 |
| Abbott Research Demonstrates Viability of Combining Antibody Functions to Target Two or More Disease-Causing Processes |
8-Nov-2007 |
| New Web Site Tools Help Alleviate Stress Associated with Caring for Children with Diabetes During the Holidays |
8-Nov-2007 |
| Abbott to Present at Credit Suisse Healthcare Conference |
7-Nov-2007 |
| Abbott Confirms FDA Advisory Panel to Review XIENCE(TM) V Drug Eluting Stent on November 29 |
5-Nov-2007 |
| Abbott's Investigational SIMCOR(R) Offers Comparable LDL Lowering to Simvastatin and Significantly Raises HDL and Lowers Triglycerides in Phase III Study |
4-Nov-2007 |
| Abbott Launches Fruitified(TM) ZonePerfect(R) All-Natural Nutrition Bars |
1-Nov-2007 |
| Abbott Researchers Target Neuronal Nicotinic Receptors for Treatment of Pain and Cognition |
1-Nov-2007 |
| Abbott Employees Provide Healthy Treats to Ghosts and Goblins Across United States |
29-Oct-2007 |
| Abbott Again Honored as a Leader in Diversity |
26-Oct-2007 |
| ZonePerfect(R) Survey Finds Americans Are Overfed on Technology, Underfed at the Dinner Table |
25-Oct-2007 |
| Abbott Named to Science Magazine's List of 'Top Employers' in the Biotech and Pharmaceutical Industry |
24-Oct-2007 |
| Real-World Studies of Carotid Artery Stenting Demonstrate Results Comparable to Guidelines for Patients Treated With Surgery |
23-Oct-2007 |
| Abbott Announces Positive One-Year Results from the World's First Clinical Trial of a Fully Bioabsorbable Drug Eluting Coronary Stent |
22-Oct-2007 |
| Abbott's XIENCE(TM) V Everolimus Eluting Coronary Stent Shows Continued Superiority to TAXUS Stent in Reducing Major Adverse Cardiac Events in SPIRIT III Clinical Trial |
22-Oct-2007 |
| Abbott's m2000(TM) Molecular Diagnostic Instrument and RealTime HIV-1 Test Win Chicago Innovation Award |
22-Oct-2007 |
| Abbott Scientists Create One Molecule With Two Antibody Functions |
18-Oct-2007 |
| Abbott Named One of the Best Companies for Hispanics by Hispanic Business Magazine |
10-Oct-2007 |
| Abbott Named One of the 'Best Places to Launch a Career' by BusinessWeek |
3-Oct-2007 |
| National Laboratory Associations Come Together in Support of 'Labs Are Vital' Initiative |
2-Oct-2007 |
| Abbott Broadens Use of i-STAT Handheld Blood Analyzer with CLIA Waiver Granted by FDA for CHEM8+ Test Cartridge |
2-Oct-2007 |
| Abbott's HUMIRA(R) (adalimumab) Honored With Prestigious Galen Prize for Innovation in Patient Care |
27-Sep-2007 |
| Abbott Initiates Clinical Study to Evaluate Use of RX Herculink(R) Elite(TM) Renal Stent System for the Treatment of Renal Artery Stenosis |
25-Sep-2007 |
| Abbott Again Honored as Top Company for Working Moms |
25-Sep-2007 |
| Abbott Declares 335th Consecutive Quarterly Dividend |
14-Sep-2007 |
| Abbott Awards Arizona Mother $135,000 in National Similac(R) Contest |
13-Sep-2007 |
| PHOTO ADVISORY -- Abbott Launches NutriPals(TM) Fruit Bars With One Serving of Real Fruit in Every Bar |
12-Sep-2007 |
| Abbott Launches NutriPals(TM) Fruit Bars With One Serving of Real Fruit in Every Bar |
12-Sep-2007 |
| Dow Jones Sustainability Index Again Recognizes Abbott for Continued Leadership in Business, Environmental and Social Performance |
10-Sep-2007 |
| Dr. Abbott's House Earns Historic Landmark Award from City of Chicago |
6-Sep-2007 |
| Abbott to Present at Bear Stearns Healthcare Conference |
4-Sep-2007 |
| Abbott and AstraZeneca Announce Selection of Next-Generation Fenofibrate ABT-335 and CRESTOR(R) Fixed-Dose Combination |
31-Aug-2007 |
| Abbott's Similac(R) Organic Brand Releases New Mom and Baby Yoga DVD |
30-Aug-2007 |
| Abbott Vascular Launches Crossroads Institute in Japan |
9-Aug-2007 |
| Abbott Receives Supplemental FDA Approval for its Best-in-Class in Sensitivity RealTime HIV-1 Viral Load Test |
9-Aug-2007 |
| Abbott Chief Operating Officer Richard A. Gonzalez to Retire |
3-Aug-2007 |
| The Princeton Review Names Abbott One of the 'Best Companies for Entry-Level Jobs' |
31-Jul-2007 |
| Abbott and Abbott Fund Expand Commitment to Fight Pediatric HIV/AIDS in Africa With $12 Million in New Support |
20-Jul-2007 |
| Abbott Submits E.U. and U.S. Regulatory Filings for New Lower-Strength Kaletra(R) and Aluvia(R) (lopinavir/ritonavir) Tablet Suitable for Pediatric Use in HIV/AIDS |
20-Jul-2007 |
| Abbott Enrolls First Patient in World's First Clinical Trial Designed to Study Drug Eluting Stent Treatment in Women |
19-Jul-2007 |
| Abbott Announces New Products, Data and Positive Initiatives at 2007 AACC Annual Meeting |
18-Jul-2007 |
| Abbott Reports 15.8 Percent Sales Growth in Second Quarter |
18-Jul-2007 |
| Studies Confirm Rise of HIV Variant Strains in the United States and Importance of Reliable Viral Load Testing |
17-Jul-2007 |
| Abbott Announces Approval of First Fully-Automated Blood Screening Test for Hepatitis C Antibodies |
12-Jul-2007 |
| Abbott Announces Termination of Contract With GE |
11-Jul-2007 |
| Abbott Goes 'Carbon Neutral' with U.S. Fleet |
11-Jul-2007 |
| Abbott Hosts Conference Call for Second-Quarter Earnings |
11-Jul-2007 |
| New Study in Journal of Pediatrics Suggests Synagis(R) (Palivizumab) May Reduce Subsequent Recurrent Wheezing in Preterm Infants |
29-Jun-2007 |
| Abbott and Abbott Fund Expand Commitment to Improving Health Care in Tanzania With Dedication of New Lab and Launch of New Diagnostic Programs |
27-Jun-2007 |
| Abbott and Genentech Announce Global, Integrated Research, Development and Commercialization Collaboration in Oncology |
26-Jun-2007 |
| Glucerna(R) Cereal Survey Finds People with Diabetes Experience 'Breakfast Envy' |
25-Jun-2007 |
| Chicago HealthFest Promises a Dose of Healthy Fun for the Whole Family |
19-Jun-2007 |
| Nearly One-Third of Chicagoans Know Little or Nothing About Diabetes, Survey Says |
18-Jun-2007 |
| Three Studies Suggest Abbott's HUMIRA(R) (adalimumab) May Improve Work Productivity in Patients with Rheumatoid Arthritis |
15-Jun-2007 |
| Abbott Declares 334th Consecutive Quarterly Dividend |
14-Jun-2007 |
| Global Business Coalition on HIV/AIDS, TB and Malaria (GBC) Honors Abbott and Abbott Fund for Efforts to Fight HIV/AIDS in Tanzania |
13-Jun-2007 |
| Abbott to Present at Goldman Sachs Healthcare Conference |
12-Jun-2007 |
| Abbott's HUMIRA(R) (Adalimumab) Approved in the European Union for the Treatment of Crohn's Disease |
7-Jun-2007 |
| Abbott and Caprion Extend Partnership to Discover Antibody Targets for Cancer |
6-Jun-2007 |
| Abbott Receives European CE Mark Approval for FreeStyle Navigator(R) Continuous Glucose Monitoring System |
6-Jun-2007 |
| First Bright Space Developed to Give Children Living With Substance Abuse a Dedicated Play and Learning Environment |
4-Jun-2007 |
| Abbott Signs Agreement With Novation for Diagnostic Equipment and Tests |
4-Jun-2007 |
| Abbott Submits XIENCE(TM) V Everolimus Eluting Coronary Stent System Application for U.S. FDA Approval |
1-Jun-2007 |
| Americans Optimistic About the War on Cancer, but Recognize a Long Road May Be Ahead |
31-May-2007 |
| Abbott Fund Increases Commitment to Fight Against HIV/AIDS in Tanzania, Opening Country's First Corporate Foundation Office |
29-May-2007 |
| Abbott Announces Voluntary Nationwide Recall of Three Lots of Two-Ounce Bottles of Similac Special Care 24 Cal / fl. oz. Ready-to-Feed (RTF) Premature Infant Formula With Iron |
25-May-2007 |
| Abbott Diagnostics Issues Voluntary Nationwide Recall of ARCHITECT(R) STAT Troponin-I Test |
25-May-2007 |
| Abbott to Present at Bank of America Health Care Conference |
25-May-2007 |
| Abbott Initiates First Clinical Study of Everolimus Eluting Stent System for Patients with Peripheral Arterial Disease |
23-May-2007 |
| Abbott Announces Positive Nine-Month Results From the World's First Clinical Trial of a Fully Bioabsorbable Drug Eluting Coronary Stent |
22-May-2007 |
| Abbott Announces Continued Positive Results with XIENCE(TM) V Everolimus Eluting Coronary Stent in SPIRIT Clinical Trials |
22-May-2007 |
| New Analysis of Data Shows Treatment With Abbott's HUMIRA(R) (Adalimumab) Significantly Reduced Disease-Related Hospitalization for Patients with Crohn's Disease |
22-May-2007 |
| Abbott to Present New Data on Next-Generation Drug-Eluting Stent Systems During EuroPCR 2007 |
18-May-2007 |
| Abbott Introduces Expanded Line of Similac(R) Infant Formulas to Help Moms Solve Their Babies' Nutritional Needs |
17-May-2007 |
| Abbott Named Among the Best Places to Work for Scientists |
16-May-2007 |
| Abbott's HIV-1 Viral Load Test Approved by FDA for Use on New m2000(TM) Molecular Diagnostics Instrument |
11-May-2007 |
| Abbott Highlights Strong Performance in Corporate Social Responsibility in 2006 Global Citizenship Report |
9-May-2007 |
| Abbott Seeks U.S. and E.U. Regulatory Approvals for HUMIRA(R) (Adalimumab) as a Treatment for Juvenile Rheumatoid Arthritis |
7-May-2007 |
| Abbott's Investigational Treatment ABT-874 Shows Positive Results in Phase II Psoriasis Study |
4-May-2007 |
| Survey Reveals Bostonians are Biotech-Savvy |
3-May-2007 |
| Abbott Named Among the 'Top 10' on The Dave Thomas Foundation's '100 Best Adoption-Friendly Workplaces' List |
30-Apr-2007 |
| Abbott Reviews 2006 Accomplishments at Annual Shareholders' Meeting |
27-Apr-2007 |
| Abbott's HUMIRA(R) (Adalimumab) Receives Positive Opinion from European Medicines Agency for the Treatment of Crohn.s Disease |
27-Apr-2007 |
| Abbott Announces New Glucerna(R) Cereal, Shakes and Snack Bars Designed to Spike Taste Buds, Not Blood Sugar for People with Diabetes |
26-Apr-2007 |
| Abbott Fund Raises Awareness About Malaria Through New Nationwide Education Program |
25-Apr-2007 |
| Abbott to Present at Morgan Stanley Healthcare Conference |
25-Apr-2007 |
| Abbott and Abbott Fund Provide $1 Million to HealthReach to Increase Access to Care and Expand Services at Area's Only Free Health Clinics |
23-Apr-2007 |
| Abbott Fund and HealthReach Announce Significant New Partnership to Expand Access to Health Care for People in Need in Lake County |
20-Apr-2007 |
| Abbott Submits New Drug Application for Combination Niaspan(R)/Simvastatin Tablet |
20-Apr-2007 |
| Abbott Reports 15.5 Percent Sales Growth in First Quarter |
18-Apr-2007 |
| Abbott and Premier Sign Contract for Diagnostic Tests |
16-Apr-2007 |
| Abbott Announces FDA Clearance and Launch of New FreeStyle Lite(TM) Blood Glucose Monitoring System |
16-Apr-2007 |
| Abbott Researchers Focus on New Cutting-Edge Approaches in the Fight Against Cancer |
13-Apr-2007 |
| Abbott Hosts Conference Call for First-Quarter Earnings |
11-Apr-2007 |
| PHOTO ADVISORY -- Abbott Opens New Biotechnology Manufacturing Facility in Puerto Rico |
10-Apr-2007 |
| Abbott Opens New Biotechnology Manufacturing Facility in Puerto Rico |
10-Apr-2007 |
| Abbott Agrees With World Health Organization (WHO) Director-General to Expand Access to Kaletra/Aluvia (lopinavir/ritonavir) |
10-Apr-2007 |
| Abbott Announces FDA Approval of a New Coated Niaspan Tablet |
6-Apr-2007 |
| Abbott Seeks U.S. and E.U. Regulatory Approval for HUMIRA(R) (Adalimumab) in Psoriasis |
2-Apr-2007 |
| Two Abbott Studies Reaffirm Carotid Artery Stenting as a Safe and Effective Treatment to Reduce Risk of Stroke |
26-Mar-2007 |
| Abbott Announces Positive Six-Month Results From the World's First Clinical Trial of a Fully Bioabsorbable Drug-Eluting Coronary Stent |
24-Mar-2007 |
| Abbott's XIENCE(TM) V Everolimus Eluting Coronary Stent Superior to TAXUS(R) Stent in SPIRIT III U.S. Pivotal Clinical Trial |
24-Mar-2007 |
| Abbott Named to DiversityInc's 'Top 50 Companies for Diversity' List |
23-Mar-2007 |
| Abbott to Present New Data Across its Vascular Portfolio at the American College of Cardiology's 56th Annual Scientific Session |
19-Mar-2007 |
| Abbott's Similac(R) Brand to Reward Mom's Hard Work with $135,000 Salary |
15-Mar-2007 |
| Abbott to Present at SG Cowen Health Care Conference |
7-Mar-2007 |
| Abbott Donates Diagnostic Equipment and Supplies to 16 Clinical Laboratory Programs as Part of 'Labs are Vital(TM)' Initiative |
5-Mar-2007 |
| HUMIRA(R) (Adalimumab) Receives FDA Approval For Treatment of Crohn's Disease |
27-Feb-2007 |
| Abbott Announces 10.2 Percent Increase in Quarterly Dividend |
16-Feb-2007 |
| Abbott Statement Regarding CMS' Proposed Expansion of Coverage for Carotid Artery Stenting |
6-Feb-2007 |
| Abbott to Initiate First Study to Evaluate XIENCE(TM) V Everolimus Eluting Coronary Stent System in Treatment of Women With Cardiovascular Disease |
6-Feb-2007 |
| Psoriasis Patients Show Significant Improvement in Symptoms with Abbott's HUMIRA(R) in New Phase III Study |
2-Feb-2007 |
| Abbott to Present at Merrill Lynch Health Care Conference |
2-Feb-2007 |
| Abbott Reports Strong Fourth-Quarter Results and Record Operating Cash Flow in 2006 |
24-Jan-2007 |
| Abbott Nutrition to Host 'The ZonePerfect(R) Bar' Music Series at 2007 Sundance Film Festival |
22-Jan-2007 |
| Abbott To Sell Its Core Laboratory Diagnostics Business, Including Point Of Care, To GE For $8.13 Billion |
18-Jan-2007 |
| Private-Label Version of Abbott's XIENCE(TM)V Drug-Eluting Coronary Stent System Launches in Europe |
11-Jan-2007 |
| Abbott m2000(TM) Molecular Diagnostic Instrument and Viral Load Tests for HIV-1 and HCV Approved in Canada |
8-Jan-2007 |
| Abbott Employees Give Back This Holiday Season |
22-Dec-2006 |
| Abbott Hosts Conference Call for Fourth-Quarter and Full-Year 2006 Earnings |
21-Dec-2006 |
| Abbott to Voluntarily Delist From NYSE Arca; Company Retains New York Stock Exchange Listing |
20-Dec-2006 |
| Abbott to Present at 2007 JP Morgan Healthcare Conference |
20-Dec-2006 |
| Abbott Completes Acquisition of Kos Pharmaceuticals, Inc. |
15-Dec-2006 |
| Abbott Fund Supports Pioneering Malaria Education Program |
14-Dec-2006 |
| Abbott Acquires a Majority of Shares of Kos Pharmaceuticals, Inc. |
13-Dec-2006 |
| Abbott and Enanta Form Worldwide Alliance to Develop and Commercialize HCV Protease Inhibitors |
12-Dec-2006 |
| Abbott Declares 332nd Consecutive Quarterly Dividend |
8-Dec-2006 |
| Abbott to Participate in RBC Capital Markets Healthcare Conference |
6-Dec-2006 |
| Abbott's Acquisition of Kos Pharmaceuticals, Inc. Clears Antitrust Review |
4-Dec-2006 |
| Abbott Introduces CE-Marked DNA Tests in Europe for the Detection of Chromosomal Abnormalities Associated With Leukemia |
4-Dec-2006 |
| Earvin 'Magic' Johnson and Abbott Announce Major Initiative on World AIDS Day to Help Reduce New HIV/AIDS Infections Among African Americans |
1-Dec-2006 |
| Abbott Again Recognized for Commitment to Environmental Excellence and Pollution Prevention |
30-Nov-2006 |
| Abbott Nutrition's EAS(R) Brand to Enter Into Relationship With the National Basketball Players' Association |
20-Nov-2006 |
| Abbott Laboratories Commences Tender Offer for All Outstanding Shares of Kos Pharmaceuticals, Inc. |
14-Nov-2006 |
| Abbott's HUMIRA(R) (adalimumab) Receives FDA Approval for Inhibiting Structural Joint Damage and Improving Physical Function in Patients With Psoriatic Arthritis |
14-Nov-2006 |
| Finding the Next Einstein: Abbott Hosts Science Day for Local Students |
10-Nov-2006 |
| Abbott to Present at Credit Suisse Healthcare Conference |
8-Nov-2006 |
| Abbott to Expand Presence in Lipid Management Market With Acquisition of Kos Pharmaceuticals |
6-Nov-2006 |
| Abbott Fund, Baylor College of Medicine and the First Lady of Malawi Open the First Clinic for HIV-Infected Children in Malawi |
2-Nov-2006 |
| Abbott's HUMIRA(R) (Adalimumab) Granted FDA Priority Review for the Treatment of Moderately to Severely Active Crohn's Disease |
26-Oct-2006 |
| Abbott Reports Positive Subset Results for XIENCE(TM) V in Tough-to-Treat Diabetic Patients |
25-Oct-2006 |
| Abbott Reports Initial Results From World's First Clinical Trial Featuring a Fully Bioabsorbable Drug-Eluting Coronary Stent |
24-Oct-2006 |
| New Phase III Data Shows Abbott's HUMIRA(R) (Adalimumab) Induced Clinical Remission In Patients With Crohn's Disease Who Lost Response to, or Were Intolerant to, Remicade(R) (Infliximab) |
23-Oct-2006 |
| Abbott Signs Exclusive Worldwide Distribution Agreement With Verax Biomedical for Rapid Platelet Bacteria Test |
20-Oct-2006 |
| Abbott Reports Strong Third-Quarter Results, Announces $2.5 Billion Share Repurchase Program |
18-Oct-2006 |
| Abbott Announces $2.5 Billion Share Repurchase Program |
18-Oct-2006 |
| Abbott to Present New Data Across Its Vascular Portfolio at TCT 2006 |
17-Oct-2006 |
| Blood Systems Laboratories Selects ABBOTT PRISM(R) System and Assays for Automated Blood Screening |
16-Oct-2006 |
| Abbott Hosts Conference Call for Third-Quarter Earnings |
11-Oct-2006 |
| Abbott Awards Virginia Mother $130,000 in National Similac(R) Contest |
11-Oct-2006 |
| New Phase III Data Show Abbott's HUMIRA(R) (Adalimumab) Was Statistically Superior to Methotrexate in Patients With Psoriasis |
5-Oct-2006 |
| U.S. Olympic Gold Medalist and New Mom Summer Sanders Becomes First Member of Innovative New Parenting Network, the Similac(R) Moms Alliance(TM) |
5-Oct-2006 |
| Abbott Begins Early International Launch of XIENCE(TM) V Everolimus Eluting Coronary Stent System |
3-Oct-2006 |
| Abbott to Provide a Free Blood Glucose Monitoring System to All Becton, Dickinson BD Logic(R) Patients |
29-Sep-2006 |
| Solving the Snack Time Food Fight: Abbott's New PediaSure(R) NutriPals(TM) Provide a Nutritious Snacking Option for Kids |
26-Sep-2006 |
| Abbott Named One of Nation's 'Top 10' Employers for Working Moms |
25-Sep-2006 |
| Operation Smile Honors Abbott With Corporate Humanitarian Award |
22-Sep-2006 |
| Abbott Voluntarily Issues a Nationwide Recall for One Lot of Alimentum, Two Lots of Similac Advance Liquid Infant Formula Ready-to-Feed 32-Ounce Plastic Bottles and One Lot of Hospital Discharge Kits |
15-Sep-2006 |
| Abbott Again Named to Dow Jones Sustainability Index for Leadership in Business, Social, Environmental Performance |
14-Sep-2006 |
| Abbott to Present at Merrill Lynch Healthcare Conference |
13-Sep-2006 |
| One in Three Parents Surveyed Unaware of Easy Ketone Test That May Help Prevent the Onset of Diabetic Ketoacidosis (DKA) |
13-Sep-2006 |
| Abbott Announces European Launch of Next-Generation Device Designed to Treat Patients at Risk of Stroke |
13-Sep-2006 |
| Abbott Announces Continued Expansion of Vascular Operations in Ireland to Prepare for Drug Eluting Stent Manufacturing |
12-Sep-2006 |
| Abbott Declares 331st Consecutive Quarterly Dividend |
8-Sep-2006 |
| Abbott Submits U.S. and E.U. Regulatory Applications Seeking Approval for HUMIRA(R) (Adalimumab) as a Treatment for Crohn's Disease |
7-Sep-2006 |
| Abbott Signs Agreement with American Red Cross for Blood Screening with Four Key Tests |
6-Sep-2006 |
| Abbott to Present at Bear Stearns Healthcare Conference |
5-Sep-2006 |
| Abbott's XIENCE V(TM) Drug-Eluting Coronary Stent Superior to TAXUS(R) Stent in SPIRIT II Clinical Trial |
5-Sep-2006 |
| Abbott Announces Completion of Enrollment in Groundbreaking Vulnerable Plaque Study |
30-Aug-2006 |
| Abbott Announces Conference Call and Key Activities at World Congress of Cardiology 2006 |
28-Aug-2006 |
| Rising Medical Costs Biggest Challenge for Diabetes Patients in Managing the Condition |
22-Aug-2006 |
| Abbott Enrolls First Patient in New Clinical Trial of XIENCE(TM) V Drug Eluting Stent |
14-Aug-2006 |
| Abbott's HUMIRA(R) (Adalimumab) Receives FDA Approval for Treatment of Ankylosing Spondylitis |
31-Jul-2006 |
| Abbott Receives FDA Clearance for i-STAT(R) BNP Test to Diagnose Congestive Heart Failure |
26-Jul-2006 |
| Abbott to Preview m2000(TM) Real-Time PCR Diagnostics System Designed to Provide Fast, Efficient Testing in the Molecular Lab |
21-Jul-2006 |
| Abbott Reminds U.S. FreeStyle(R) and FreeStyle Flash(R) Blood Glucose Meter Users to Verify Units of Measure When They Test |
20-Jul-2006 |
| New Study in Journal of Urology Shows UroVysion(TM) DNA Test Superior to Standard Cytology in Diagnosing Bladder Cancer in At-Risk Patients |
20-Jul-2006 |
| Abbott Announces FDA Clearance of Cell-Dyn Ruby(TM) Hematology Instrument |
19-Jul-2006 |
| Abbott Announces Strong Second-Quarter Results and Raises Full-Year Earnings Outlook |
19-Jul-2006 |
| Abbott Announces Approval of First Fully-Automated Blood Screening Tests for Hepatitis B Surface Antigen |
18-Jul-2006 |
| Abbott Hosts Conference Call for Second-Quarter Earnings |
12-Jul-2006 |
| Abbott and Dharmacon Collaborate to Develop New siRNA-Based Therapeutics |
6-Jul-2006 |
| Abbott and AstraZeneca Announce Collaboration to Develop and Commercialize CRESTOR(R) and Next-Generation TriCor(R) (ABT-335) Fixed-Dose Combination |
5-Jul-2006 |
| Abbott's New Tablet Formulation of Kaletra(R) (lopinavir/ritonavir) Approved in Europe |
3-Jul-2006 |
| Abbott Enters Agreement With Cincinnati Children's Hospital to Develop Test to Detect Acute Kidney Failure |
27-Jun-2006 |
| Abbott Receives FDA Approval for New HUMIRA(R) Delivery Device |
26-Jun-2006 |
| New Phase III Data Demonstrate That Abbott's HUMIRA(R) (Adalimumab) Sustained Reduction in Signs and Symptoms Through One Year in Patients With Ankylosing Spondylitis |
23-Jun-2006 |
| Abbott Declares 330th Consecutive Quarterly Dividend |
16-Jun-2006 |
| New Study Assesses Accuracy of Abbott's Investigational FreeStyle Navigator(TM) Continuous Glucose Monitoring System |
13-Jun-2006 |
| Abbott's Investigational FreeStyle Navigator(TM) Continuous Glucose Monitoring System Shows Promise in Two New Studies |
10-Jun-2006 |
| Abbott to Present at Goldman Sachs Health Care Conference |
7-Jun-2006 |
| Abbott's HUMIRA(R) (Adalimumab) Approved in the European Union for Treatment of Severe Ankylosing Spondylitis |
7-Jun-2006 |
| Abbott Helps Children With Diabetes by Sending Them to Camp This Summer |
6-Jun-2006 |
| Promising Pivotal Phase III Data Show Abbott's Humira(R) (Adalimumab) Maintained Clinical Remission in Patients With Crohn's Disease Through One Year |
22-May-2006 |
| Clinical Benefits of UroVysion(R) DNA Test Highlighted by Bladder Cancer Experts in Urology |
17-May-2006 |
| Abbott Enters Agreement With Advanced Life Science Institute to Develop Lung Cancer Test |
16-May-2006 |
| Abbott Announces First Patients Enrolled in ZOMAXX(TM) EUROPE Clinical Trial |
15-May-2006 |
| Abbott to Present at Banc of America Securities Health Care Conference |
9-May-2006 |
| Abbott's New Tablet Formulation of Kaletra(R) (Lopinavir/Ritonavir) Receives Positive Opinion From the European Medicines Agency |
28-Apr-2006 |
| Abbott's HUMIRA(R) (Adalimumab) Receives Positive Opinion From European Medicines Agency for the Treatment of Ankylosing Spondylitis |
28-Apr-2006 |
| Abbott Named in the Top 10 in the Annual List of DiversityInc's Top 50 Companies |
25-Apr-2006 |
| Abbott Completes Acquisition of Guidant Vascular Business |
21-Apr-2006 |
| Abbott Hosts Special Conference Call to Discuss Guidant Vascular Transaction |
20-Apr-2006 |
| Abbott Acquisition of Guidant's Vascular Business Clears U.S. Antitrust Review |
20-Apr-2006 |
| Abbott Reports First Quarter Results Led by Strong Medical Products Performance |
19-Apr-2006 |
| Abbott Receives European Commission Clearance for Acquisition of Guidant's Vascular Business |
11-Apr-2006 |
| Abbott Hosts Conference Call For First-Quarter Earnings |
11-Apr-2006 |
| Myriad and Abbott Enter Into Broad Discovery Collaboration |
11-Apr-2006 |
| Abbott and Earvin 'Magic' Johnson Announce Partnership |
7-Apr-2006 |
| Abbott Diabetes Care Named One of the Best Places to Work in San Francisco Bay Area |
6-Apr-2006 |
| Abbott Donates $1 Million to Encourage Chicago's Science Leaders of Tomorrow |
6-Apr-2006 |
| Chicagoans Unfamiliar with Biotechnology, Yet Believe It Enhances Lives |
6-Apr-2006 |
| Abbott Files for Registration of Innovative Formulation for the Treatment of HIV In South Africa |
3-Apr-2006 |
| Abbott and Morgan Stanley Welcome the 14th Annual International Biotechnology Convention to Chicago for Its Midwestern Debut |
31-Mar-2006 |
| Abbott Announces Jeffrey M. Leiden to Step Down |
21-Mar-2006 |
| Abbott Statement on Advancing Pediatric HIV Treatment in Developing Countries |
13-Mar-2006 |
| Abbott Receives FDA 510K Clearance to Market FreeStyle(R) Freedom(TM) Blood Glucose Monitoring System |
13-Mar-2006 |
| Abbott Reports Positive Results From First Human Clinical Trial Featuring ZoMaxx(TM) Drug-Eluting Coronary Stent |
12-Mar-2006 |
| Medialink: Living With Epilepsy |
9-Mar-2006 |
| Multimedia Available: Medialink: Living With Epilepsy |
9-Mar-2006 |
| Survey Finds People With Diabetes Want to Live Healthier But Face Challenges in Identifying Affordable Tools to Control the Condition |
7-Mar-2006 |
| Abbott Launches New Specialty Catheter Technology in U.S. |
24-Feb-2006 |
| Abbott Launches First Complete Blood Glucose Monitoring System Designed for Diabetic Cats and Dogs |
21-Feb-2006 |
| Abbott Announces Increase in Quarterly Dividend |
17-Feb-2006 |
| Abbott to Present at Merrill Lynch Health Care Conference |
1-Feb-2006 |
| Abbott Reports Record Sales, Earnings and Cash Flow in 2005 |
25-Jan-2006 |
| Abbott Receives FDA 510(K) Clearance for i-STAT(R) CHEM 8+ Cartridge |
25-Jan-2006 |
| New Real-Time PCR Test for Chlamydia and Gonorrhea Receives CE Mark Certification |
23-Jan-2006 |
| W. James Farrell Named to Abbott Board of Directors |
20-Jan-2006 |
| Abbott Hosts Conference Call for Fourth-Quarter and Full-Year 2005 Earnings |
18-Jan-2006 |
| Abbott Announces Amendment to Agreement With Boston Scientific to Acquire Guidant's Vascular Business |
17-Jan-2006 |
| Abbott to Acquire Guidant Vascular Business Contingent Upon Close of Boston Scientific's Proposed Acquisition of Guidant |
8-Jan-2006 |
| Abbott Does Not Endorse Below-Market Mini-Tender Offer From TRC Capital |
6-Jan-2006 |
| Abbott Receives FDA Approval for StarClose(TM) Vascular Closure System |
22-Dec-2005 |
| Abbott Announces 2006 Earnings Guidance |
15-Dec-2005 |
| Abbott Declares 328th Consecutive Quarterly Dividend |
9-Dec-2005 |
| Reinvented Bodies, Rejuvenated Lives: Who Will Win The $1 Million Prize? Public to Decide |
8-Dec-2005 |
| Abbott's Depakote(R) ER (Divalproex Sodium Extended-Release Tablets) Approved for Acute Manic or Mixed Episodes Associated With Bipolar Disorder |
7-Dec-2005 |
| Abbott Fund Supports Pioneering Programs Improving the Health of Women and Children |
28-Nov-2005 |
| Abbott to Participate in Merrill Lynch Med Tech Fundamentals Conference |
23-Nov-2005 |
| New Data Show a Kaletra(R) (Lopinavir/Ritonavir)-Based Regimen Demonstrated Continued Efficacy and Favorable Resistance Profile for Patients Through Seven Years of Initial HIV Therapy |
18-Nov-2005 |
| Abbott Reports Levosimendan (Simdax(R)) Results From Large Mortality Trial in Patients With Acute Decompensated Heart Failure |
16-Nov-2005 |
| Abbott to Acquire License to Johnson & Johnson's Rapid Exchange Catheter Delivery Technology |
15-Nov-2005 |
| Abbott Statement on FIELD Study Presented at American Heart Association Meeting and Published in The Lancet |
14-Nov-2005 |
| Abbott Reports Improved Clinical Course With Levosimendan (Simdax(R)) When Added to Standard Therapy in Acute Decompensated Heart Failure Trial |
14-Nov-2005 |
| Abbott's ATLAS Study Shows Significant Reduction in Signs and Symptoms and Improvement in Health-Related Quality of Life for Ankylosing Spondylitis Patients Taking HUMIRA(R) (Adalimumab) |
13-Nov-2005 |
| HUMIRA(R) (Adalimumab) Shows Promise in Treating Patients With Rheumatoid Arthritis Who Previously Failed Anti-TNF Treatment |
13-Nov-2005 |
| Abbott to Present New Data on Investigational Compounds at Society for Neuroscience Annual Meeting |
11-Nov-2005 |
| U.S. District Court Grants Abbott's Request for a Preliminary Injunction Against Biaxin(R) XL Generics |
10-Nov-2005 |
| Abbott's HUMIRA(R) (Adalimumab) Shows Promising Results in Long-Term Treatment of Crohn's Disease, According to Phase III Study |
31-Oct-2005 |
| Abbott Receives FDA Approval for New Kaletra(R) (Lopinavir/Ritonavir) Tablet Formulation for HIV Patients |
31-Oct-2005 |
| Craving Pureed Peas & Plums Lands Mar Vista, Calif. Resident $10,000 |
24-Oct-2005 |
| Abbott Reports 15.0 Percent Sales Increase in the Third Quarter |
19-Oct-2005 |
| Abbott Issues Nationwide Urgent Medical Device Correction for Blood Glucose Meters |
14-Oct-2005 |
| Abbott Advances Blood Bank Testing Technology With U.S. Launch of Abbott PRISM(R) |
13-Oct-2005 |
| Abbott's PathVysion(TM) Is One of 10 Products to Win 2005 Chicago Innovation Award |
11-Oct-2005 |
| Abbott to Host Conference Call for Third-Quarter Earnings |
6-Oct-2005 |
| Nationwide Strengthening of Hospital System in Tanzania Marks New Era in Fight Against AIDS in Africa |
6-Oct-2005 |
| Abbott Announces U.S. and E.U. Regulatory Submissions Seeking Approval of HUMIRA(R) (Adalimumab) in Ankylosing Spondylitis (AS) |
4-Oct-2005 |
| HUMIRA(R) (Adalimumab) Receives FDA Approval for Treatment of Psoriatic Arthritis |
4-Oct-2005 |
| HUMIRA(R) (adalimumab) Receives FDA Approval for First-Line Treatment of Moderate to Severe Rheumatoid Arthritis |
4-Oct-2005 |
| Abbott Named to Dow Jones Sustainability Index for Leadership in Corporate Citizenship |
3-Oct-2005 |
| Abbott Named to Science Magazine's 2005 List of 'Top Employers' in the Biotech and Pharmaceutical Industry |
30-Sep-2005 |
| Abbott Dedicates New Molecular Diagnostics Headquarters in Des Plaines, Ill. |
29-Sep-2005 |
| Abbott Initiates Clinical Trial to Study New Option for Treatment of Lower Back Pain |
28-Sep-2005 |
| Abbott Receives U.S. Approval for New Device Designed to Treat Patients at Risk of Stroke |
15-Sep-2005 |
| FDA Advisory Committee Does Not Recommend Approval of Xinlay(TM) (atrasentan) |
13-Sep-2005 |
| Abbott Continues to Gain Recognition as One of the Nation's Best Employers for Working Mothers |
12-Sep-2005 |
| Abbott Declares 327th Consecutive Quarterly Dividend |
9-Sep-2005 |
| Abbott to Present at Bear Stearns Healthcare Conference |
6-Sep-2005 |
| Abbott Statement on Contributions to Hurricane Katrina Relief Efforts |
31-Aug-2005 |
| Abbott Makes FORTUNE's List of the Best Companies for Minorities for Eighth Consecutive Year |
26-Aug-2005 |
| Abbott Statement Regarding U.S. Food and Drug Administration's Denial of Public Citizen's Petition Against Meridia(R) (sibutramine HCL monohydrate) Capsules C-IV |
17-Aug-2005 |
| Abbott Receives FDA Clearance to Market FreeStyle Connect(TM) Blood Glucose Monitoring System |
15-Aug-2005 |
| HUMIRA(R) (Adalimumab) Approved in Europe for the Treatment of Psoriatic Arthritis and as a First-Line Treatment of Severe Rheumatoid Arthritis |
15-Aug-2005 |
| Abbott, Health Advocacy Groups Urge Thousands of Illinois Patients to Enroll in Discounted Prescriptions |
10-Aug-2005 |
| Abbott Supports PhRMA Guiding Principles for Direct-to-Consumer Advertising |
2-Aug-2005 |
| Abbott Announces Agreement with Nephromics for Preeclampsia Test |
26-Jul-2005 |
| Clinicians Stress the Importance of Tests for Reproductive Health and Thyroid Disorders During 'Trends in Women's Health Workshop' |
26-Jul-2005 |
| Abbott Announces U.S. 510(k) Clearance of CELL-DYN Sapphire(TM) Hematology Instrument |
25-Jul-2005 |
| Abbott and Celera Diagnostics Announce CE Marking for HCV Real-Time PCR Viral Load Test |
22-Jul-2005 |
| Abbott Appoints John M. Taylor III to Government Affairs Staff |
18-Jul-2005 |
| Abbott Reports 17.5 Percent Sales Increase in the Second Quarter |
13-Jul-2005 |
| Abbott Statement on Agreement With Brazilian Government for Kaletra(R) (Lopinavir/Ritonavir) |
9-Jul-2005 |
| Abbott Recognizes Winners of Supplier Excellence Award for Quality Services and Products |
7-Jul-2005 |
| Abbott Hosts Conference Call for Second-Quarter Earnings |
6-Jul-2005 |
| A Statement from Abbott/ Comunicado do Abbott |
29-Jun-2005 |
| Abbott's HUMIRA(R) (Adalimumab) Receives Positive Opinion for Treatment of Psoriatic Arthritis from the European Medicines Agency |
27-Jun-2005 |
| Abbott Receives Positive Opinion for HUMIRA(R) (Adalimumab) as First-Line Treatment of Moderate to Severe Early Rheumatoid Arthritis |
27-Jun-2005 |
| Update on Abbott's Biotechnology Research During BIO 2005 in Philadelphia |
17-Jun-2005 |
| Abbott Sponsors Youth Policy Summit on Child and Adolescent Obesity and Nutrition in America |
16-Jun-2005 |
| Actor Mark Consuelos Joins 'Diabetes Freedom' Effort |
16-Jun-2005 |
| Abbott and Celera Diagnostics Announce CE Marking for HIV-1 Real-Time PCR Viral Load Test |
16-Jun-2005 |
| Getting Arms Around Childhood Obesity Focus of Colorado Summit |
14-Jun-2005 |
| Abbott Named on Top 10 'Best Places to Work for Scientists' by The Scientist Magazine |
14-Jun-2005 |
| Abbott Declares 326th Consecutive Quarterly Dividend |
10-Jun-2005 |
| Abbott's HUMIRA(R) (Adalimumab) Shown to Improve Quality of Life for Psoriatic Arthritis Patients |
10-Jun-2005 |
| American Adults Compromise Nutrition for Convenience: National Survey Reveals Nutritional Lifestyle Habits |
9-Jun-2005 |
| Abbott's PREMIER Study Shows Early Therapy With HUMIRA(R) (adalimumab) and methotrexate May Affect Long-Term Disease Progression in Patients Battling Rheumatoid Arthritis |
8-Jun-2005 |
| Abbott to Present at the Goldman Sachs Health Care Conference |
7-Jun-2005 |
| Abbott Announces FDA Approval of Zemplar(R) (paricalcitol) Capsules for Earlier Treatment of Kidney Disease Complication |
27-May-2005 |
| Special Session Highlights Strengthening of Infrastructure in Tanzania to Fight HIV/AIDS |
25-May-2005 |
| Abbott Enrolls First Patient in Pivotal Drug-Eluting Stent Clinical Trial |
17-May-2005 |
| Abbott Data Published in Nature Reveals a Promising New Approach in Cancer |
16-May-2005 |
| New Phase III Data Shows Nearly Four Out Of Five Crohn's Patients Responded To Treatment With Abbott's HUMIRA(R) (Adalimumab) |
16-May-2005 |
| Recent College Graduates Find Success at Abbott |
12-May-2005 |
| Abbott to Present at Banc of America Securities Health Care Conference on May 17 |
10-May-2005 |
| Abbott to Present New Data on Its Oncology Pipeline at the American Society of Clinical Oncology (ASCO) Annual Meeting |
9-May-2005 |
| Abbott Submits Application to U.S. FDA for a New, More Convenient Formulation of Kaletra(R) (Lopinavir/Ritonavir) |
3-May-2005 |
| Abbott Presents Promising Zemplar(R) (Paricalcitol) Capsules Phase III Data Showing Potential for Earlier Treatment of Kidney Disease Complication |
3-May-2005 |
| Abbott Receives FDA Approval for a Once-Daily Kaletra(R)-Based (lopinavir/ritonavir) Treatment Regimen |
2-May-2005 |
| Creative Way to Calm a Fussy Baby May Win a 'Fuss-Free' Trip For Mom |
27-Apr-2005 |
| Abbott Reviews 2004 Accomplishments at Annual Shareholders' Meeting |
22-Apr-2005 |
| Abbott to Present at Morgan Stanley Healthcare Conference |
20-Apr-2005 |
| Abbott and Axis-Shield Announce U.S. 510(K) Clearance of an Automated Test for Monitoring Wyeth's Transplant Drug RAPAMUNE(R) (Sirolimus) |
19-Apr-2005 |
| Abbott Fund and Baylor College of Medicine Partner to Create the First International Network of Centers Treating Children With HIV |
14-Apr-2005 |
| Abbott Reports 16.0 Percent Sales Increase in the First Quarter |
12-Apr-2005 |
| Abbott Named No. 5 to DiversityInc's Top 50 Companies for Diversity list |
11-Apr-2005 |
| Abbott Submits StarClose(TM) Vascular Closure System for FDA Approval |
11-Apr-2005 |
| Abbott Receives FDA Approval to Begin ZOMAXX II U.S. Drug-Eluting Coronary Stent Trial |
7-Apr-2005 |
| Abbott Hosts Conference Call for First-Quarter Earnings |
5-Apr-2005 |
| Abbott Joins National Program to Help Millions of Uninsured Americans Get the Prescription Medicines They Need |
5-Apr-2005 |
| 75 Percent of Women Indulge Food Cravings During Pregnancy; Only 8 Percent Reach for Healthy Substitutes |
4-Apr-2005 |
| Abbott Fund, Baylor College of Medicine and the Government of Malawi to Build New Clinic for HIV-Infected children |
9-Mar-2005 |
| Abbott Introduces Automated Hepatitis C Test for AxSYM System |
8-Mar-2005 |
| Abbott to Present at SG Cowen Health Care Conference |
8-Mar-2005 |
| Diabetes Freedom Campaign Takes Awareness to the Streets |
3-Mar-2005 |
| Abbott Enters Into Agreement With Inpeco to Expand Laboratory Automation Capabilities |
2-Mar-2005 |
| New Phase II Data Shows Improvement in Disease Activity and Quality of Life for Psoriasis Patients With Abbott's HUMIRA(R) (adalimumab) |
18-Feb-2005 |
| Abbott Announces Increase in Quarterly Dividend |
18-Feb-2005 |
| Abbott Appoints Laura J. Schumacher Senior Vice President, Secretary and General Counsel |
18-Feb-2005 |
| Abbott and Nihon Kohden Corporation Enter Into Agreement for Automated Hematology Diagnostic Instruments |
16-Feb-2005 |
| Abbott and OraSure Technologies Enter Agreement for OraQuick(R) ADVANCE(TM) Rapid HIV-1/2 Test |
14-Feb-2005 |
| FDA Agrees to File Abbott's New Drug Application for Xinlay(TM) (Atrasentan) to Treat Metastatic Hormone-Refractory Prostate Cancer |
11-Feb-2005 |
| Abbott Enters Into Agreement With Cleveland Clinic for Myeloperoxidase (MPO) Cardiac Test |
7-Feb-2005 |
| Abbott to Present at Merrill Lynch Health Care Conference |
4-Feb-2005 |
| Similac(R) Advance(R) With Iron Powder 12.9-oz. Can Lot Number 20307RB -- Voluntary Recall |
2-Feb-2005 |
| Newly Published Study Evaluates Abbott's HUMIRA(R) in Crohn's Disease |
31-Jan-2005 |
| FDA Approves First Gene-Based Test, UroVysion(TM), for Diagnosis of Patients Suspected of Having Bladder Cancer |
25-Jan-2005 |
| Abbott Reports 15.5 Percent Sales Increase in the Fourth Quarter; 13.9 Percent Increase for 2004 |
18-Jan-2005 |
| Abbott Hosts Conference Call for Fourth-Quarter and Full-Year 2004 Earnings |
10-Jan-2005 |
| Abbott Statement on Commitment to Relief Efforts |
29-Dec-2004 |
| Abbott Announces Regulatory Submissions for Use of HUMIRA(R) (adalimumab) as First-Line Treatment for Rheumatoid Arthritis |
22-Dec-2004 |
| Abbott Announces U.S. and European Regulatory Submissions for HUMIRA(R) (adalimumab) as Treatment for Psoriatic Arthritis |
16-Dec-2004 |
| Abbott Announces 2005 Sales and Earnings Guidance |
16-Dec-2004 |
| Abbott Submits New Drug Application to U.S. FDA for Advanced Prostate Cancer Drug, Xinlay(TM) (atrasentan) |
14-Dec-2004 |
| Abbott Laboratories Declares 324th Consecutive Quarterly Dividend |
10-Dec-2004 |
| Abbott Named to Science Magazine's List of Best Pharmaceutical and Biotechnology Companies for Scientists |
29-Nov-2004 |
| United States Health and Human Services Secretary Tommy G. Thompson Applauds Effective Public-Private Partnership Advancing HIV/AIDS Care in Tanzania |
16-Nov-2004 |
| Abbott Laboratories to Present at Credit Suisse First Boston Health Care Conference |
11-Nov-2004 |
| New England Journal of Medicine Publishes Response Results of Abbott's Investigational Anti-Interleukin-12 (IL-12) Fully Human Monoclonal Antibody in Crohn's Disease Study |
10-Nov-2004 |
| Simple Steps Can Keep Families Healthy During Cold and Flu Season |
9-Nov-2004 |
| Abbott Receives FDA Approval for New Formulation of TriCor(R) (Fenofibrate) Tablets for the Treatment of Common Lipid Disorders |
5-Nov-2004 |
| Longest Study of Kaletra(R) (Lopinavir/Ritonavir) Based Regimen Demonstrated Favorable Resistance Profile for Patients Through Six Years of Initial HIV Therapy |
1-Nov-2004 |
| Superstar Patti LaBelle Encourages Americans to Manage Diabetes 365 Days a Year |
28-Oct-2004 |
| Abbott Acquires Spine Next, S.A., a Manufacturer of Non-Fusion Spinal Implant Devices |
25-Oct-2004 |
| Abbott Announces the Worldwide Launch of AxSYM(R) Troponin-I ADV Test That Aids in Heart Attack Detection |
20-Oct-2004 |
| Abbott and BioGenex Enter Agreement for Automated Molecular Diagnostics System |
19-Oct-2004 |
| Abbott Presents Promising Phase III Psoriatic Arthritis Data for HUMIRA(R) (adalimumab) |
18-Oct-2004 |
| Abbott Presents Promising Phase III Data for HUMIRA(R) (adalimumab) Plus methotrexate as First-Line Treatment in Early Rheumatoid Arthritis |
18-Oct-2004 |
| Abbott Reports 10.2 Percent Sales Increase in the Third Quarter |
14-Oct-2004 |
| Abbott Laboratories to Acquire EAS |
11-Oct-2004 |
| William M. Daley Named to Abbott Board of Directors |
8-Oct-2004 |
| Abbott Laboratories Enhances ARCHITECT(R) Systems' Fertility Menu With New Test for Estradiol |
4-Oct-2004 |
| Abbott Announces FDA Approval of New Omnicef(R) (Cefdinir) Oral Suspension Dosage for Pediatric Use |
28-Sep-2004 |
| Abbott Laboratories Hosts Conference Call for Third-Quarter Earnings |
24-Sep-2004 |
| Abbott Laboratories Again Recognized as One of the Nation's Best Employers for Working Mothers |
21-Sep-2004 |
| Abbott Laboratories to Present at Banc of America and Merrill Lynch Conferences |
15-Sep-2004 |
| Abbott's On-Site Child Care Center Recognized Amongst the Country's Best |
15-Sep-2004 |
| Abbott Laboratories Introduces Second Fully Automated Test for Hepatitis A Virus |
15-Sep-2004 |
| Abbott Vascular Devices Enrolls First Patient in Clinical Trial of the ZoMaxx(TM) Drug-Eluting Coronary Stent |
14-Sep-2004 |
| Abbott Laboratories Declares 323rd Consecutive Quarterly Dividend |
10-Sep-2004 |
| Abbott Laboratories and Axis-Shield Announce U.S. 510(K) Submission of an Automated Test for Monitoring Wyeth's Transplant Drug RAPAMUNE(R) (Sirolimus) |
9-Sep-2004 |
| Abbott Laboratories to Present at Bear Stearns Health Care Conference |
7-Sep-2004 |
| New Glucerna(R) Crispy Snack Bars Offer Tasty New Option for People With Diabetes |
7-Sep-2004 |
| Abbott Laboratories Announces US 510(K) Clearance and International Launch of Archtect(R) Stat Troponin-I Test That Aids in Heart Attack Detection |
18-Aug-2004 |
| Abbott Laboratories Increases Its Commitment to Diabetes Camps and Children With Diabetes |
12-Aug-2004 |
| FDA Approves Abbott Laboratories' HUMIRA(R) (adalimumab) to Improve Physical Function in Rheumatoid Arthritis (RA) Patients |
10-Aug-2004 |
| Ensure(R) Reclosable Bottle Wins DuPont Award for 'Design Excellence' in Packaging |
9-Aug-2004 |
| Abbott Laboratories Submits New Drug Application to U.S. FDA for Zemplar(R) (Paricalcitol) Capsules |
2-Aug-2004 |
| New Analytical Tool Developed to Evaluate the Accuracy of Continuous Glucose Monitoring |
30-Jul-2004 |
| Abbott Laboratories Announces US 510(k) Clearance and International Launch of ARCHITECT(R) STAT CK-MB Test That Assists in Heart Attack Detection |
29-Jul-2004 |
| Abbott Laboratories Presents Promising Psoriasis Study Data Showing Improvement in Disease Activity and Quality of Life With HUMIRA(R) (adalimumab) |
29-Jul-2004 |
| Abbott Laboratories Announces US 510(k) Submission Of AxSYM Troponin-I ADV Assay |
28-Jul-2004 |
| Abbott Laboratories Introduces First Fully Automated Test for Hepatitis A Virus |
27-Jul-2004 |
| Abbott Laboratories Announces Submission for Once-Daily Kaletra(R) (lopinavir/ritonavir) in United States, Europe |
26-Jul-2004 |
| Abbott Laboratories and Deltanoid Pharmaceuticals Inc. Announce Agreement to Develop Fourth Generation Active D Therapies for Renal Disease |
22-Jul-2004 |
| Abbott Laboratories Named Among Best Employers for Entry-Level Jobs by Princeton Review |
15-Jul-2004 |
| U.S. District Court Dismisses Claims Against Abbott Laboratories' Anti-Obesity Medication Meridia(R) (Sibutramine HCL Monohydrate) C-IV |
14-Jul-2004 |
| Kaletra(R) (lopinavir/ritonavir) Based Regimens Demonstrate Favorable Resistance in Clinical Trials |
14-Jul-2004 |
| Abbott Laboratories and Axis-Shield Announce U.S. 510(k) Submission and International Launch of AxSYM Testosterone Assay |
13-Jul-2004 |
| Abbott Laboratories Shares Results and Key Learnings from Programs to Fight HIV/AIDS in Developing Countries |
12-Jul-2004 |
| Abbott Reports 14 Percent Sales Increase in the Second Quarter |
9-Jul-2004 |
| Abbott Laboratories Announces Intent to Submit New Drug Application for Xinlay(TM) (Atrasentan) in the U.S. |
9-Jul-2004 |
| Abbott Laboratories Honored as One of the Top Ten Best Companies for Scientists |
8-Jul-2004 |
| Abbott Laboratories and Celera Genomics Announce Cancer Therapeutics Collaboration |
7-Jul-2004 |
| Abbott Laboratories Hosts Conference Call for Second-Quarter Earnings |
6-Jul-2004 |
| FDA Approves New Dosing Options for PREVACID(R) (LANSOPRAZOLE) SoluTab(TM) Orally Disintegrating Tablets |
6-Jul-2004 |
| PREVACID(R) (lansoprazole) Approved by FDA for Use in Adolescents |
30-Jun-2004 |
| Study Showed Children Taking Omnicef(R) (cefdinir) More Likely to Finish Their Medication Than Those Taking Augmentin for Ear Infections |
29-Jun-2004 |
| Abbott Laboratories' Statement Regarding the CMS Announcement on Medicare Demonstration Project for Self-Injectable Drugs |
25-Jun-2004 |
| U.S. Food and Drug Administration (FDA) Denies Abbott's Citizen Petition Regarding Levothyroxine Sodium Products |
23-Jun-2004 |
| Abbott Laboratories Continues to Be One of the Country's Best Companies for Minorities, Ranking No. 29 on FORTUNE's Annual List |
23-Jun-2004 |
| Abbott Laboratories Expands AxSYM Diagnostic Testing Menu |
23-Jun-2004 |
| New Campaign Aims to Inspire People With Diabetes to Experience 'Diabetes Freedom' |
22-Jun-2004 |
| Preliminary Data From Two Clinical Trials Demonstrate Abbott Laboratories' HUMIRA(R) (Adalimumab) Improved Symptoms of Psoriatic Arthritis and Ankylosing Spondylitis |
14-Jun-2004 |
| Abbott Laboratories Declares 322nd Consecutive Quarterly Dividend |
11-Jun-2004 |
| Abbott Laboratories' Statement Regarding FDA'S DDMAC Letter on Norvir(R) (Ritonavir Capsules) Materials |
10-Jun-2004 |
| ReAct Study Shows Abbott's Humira(R) (Adalimumab) Significantly Reduces Signs and Symptoms in Patients Battling Rheumatoid Arthritis |
10-Jun-2004 |
| Abbott and Protein Design Labs Announce Broad, Long-Term Collaboration for Humanized Therapeutic Antibodies |
7-Jun-2004 |
| Meta-Analysis Results Presented at ASCO Show Statistically Significant Delay in Time to Disease Progression for Advanced Prostate Cancer Patients Taking Atrasentan |
5-Jun-2004 |
| Abbott Introduces New and Improved Precision Xtra(TM) Advanced Diabetes Management System |
5-Jun-2004 |
| New Survey Shows One in 10 Moms Are Aware That Soy Formula May Help Manage Fussiness in Formula-Fed Infants |
4-Jun-2004 |
| Abbott Laboratories to Present at Goldman Sachs Health Care Conference |
3-Jun-2004 |
| Abbott Laboratories Acquires Manufacturing and Commercial Rights to Trandolapril From Aventis |
3-Jun-2004 |
| Abbott Laboratories Initiates Clinical Trial to Explore Use of Investigational Anti-Interleukin-12 (IL-12) in Multiple Sclerosis (MS) |
2-Jun-2004 |
| Abbott Laboratories Introduces 10 Clinical Chemistry Tests |
1-Jun-2004 |
| Spinal Concepts Announces Launch of Nex-Link(TM) Implant |
1-Jun-2004 |
| Spinal Concepts Launches InFix(R) Device for Spinal Surgery |
1-Jun-2004 |
| Abbott Laboratories' Zemplar(R) (Paricalcitol Injection) Receives FDA Approval for Pediatric Use |
27-May-2004 |
| Data Demonstrate Impact of Weight Loss With Sibutramine on Cardiovascular Risk Factors for Obese Patients |
26-May-2004 |
| Abbott Laboratories Comments at NIH Public Meeting Regarding Norvir and Bayh-Dole March-in Provisions |
25-May-2004 |
| Abbott Vascular Devices Unveils the StarClose Vascular Closure System |
25-May-2004 |
| Abbott Laboratories Introduces Two New Assays for Therapeutic Drug Monitoring Management |
20-May-2004 |
| Updated: Abbott Expands Its Medicare Assistance Program (MAP) to Offer Synthroid (Levothyroxine Sodium Tablets, USP) for $5 and Other Chronic Care Drugs for $12, Monthly, to Low-Income Seniors |
19-May-2004 |
| Traveling With Health Conditions - Make Adventure the Destination, Not Health Management |
19-May-2004 |
| Abbott Expands Its Medicare Assistance Program (MAP) to Offer Synthroid (Levothyroxine Sodium Tablets, USP) for $5 and Other Chronic Care Drugs for $12, Monthly, to Low-Income Seniors |
19-May-2004 |
| Abbott Laboratories Announces Positive Results of Two Clinical Trials of HUMIRA(R) (adalimumab) in Crohn's Disease |
18-May-2004 |
| Abbott Laboratories' New Investigational Anti-Interleukin-12 (IL-12) Fully Human Monoclonal Antibody Shows Positive Results in Crohn's Disease Study |
17-May-2004 |
| Abbott Laboratories to Present at Banc of America Securities Health Care Conference |
13-May-2004 |
| Scientists From Abbott Laboratories Named 2004 Inventors of the Year by the Intellectual Property Law Association of Chicago (IPLAC) for Invention of Kaletra(R) |
13-May-2004 |
| Abbott Laboratories' HUMIRA(R) (Adalimumab) Significantly Slows Disease Progression and Improves Quality of Life in Patients With Rheumatoid Arthritis |
10-May-2004 |
| Employers Have New Tool to Help Improve Workplace Productivity |
7-May-2004 |
| Abbott Laboratories Receives Positive Opinion for HUMIRA(R) Rheumatoid Arthritis Label Extension From European Medicines Evaluation Agency |
6-May-2004 |
| Data Shows Addition of Depakote(R) (Divalproex Sodium) to Atypical Antipsychotics Results in Decrease or No Change in Cholesterol |
5-May-2004 |
| Abbott Vascular Devices Launches Perclose(R) ProGlide(TM) Next Generation Suture-Mediated Vessel Closure System |
5-May-2004 |
| Abbott Laboratories to Participate in the Morgan Stanley Healthcare Unplugged Conference |
30-Apr-2004 |
| Abbott Laboratories to Present at Deutsche Bank Securities Health Care Conference |
28-Apr-2004 |
| Abbott Laboratories Reviews 2003 Accomplishments at Annual Shareholders' Meeting |
23-Apr-2004 |
| Abbott Laboratories Launches Architour, Mobile Lab Diagnostic System |
20-Apr-2004 |
| ZonePerfect Nutrition Company Sues Hershey for Trademark Violation |
15-Apr-2004 |
| Abbott Laboratories and Orion Corporation Expand Collaboration for Injectable Levosimendan |
15-Apr-2004 |
| Abbott Laboratories and artus GmBH Expand Agreement for Molecular Diagnostics Tests |
14-Apr-2004 |
| Rheumatoid Arthritis Awareness Campaign Plants a 'Can-Do' Spirit in Patients |
13-Apr-2004 |
| Abbott Laboratories Declares Special Dividend Distribution of Hospira Stock |
12-Apr-2004 |
| Abbott Reports 13.9 Percent Sales Increase in the First Quarter |
8-Apr-2004 |
| Abbott Laboratories Receives Approval From U.S. Department of Agriculture for Rapid Enfer BSE Test |
7-Apr-2004 |
| Abbott Laboratories Completes Acquisition of TheraSense |
6-Apr-2004 |
| Abbott Laboratories Hosts Conference Call for First-Quarter Earnings |
1-Apr-2004 |
| Study Suggests That Treatment for Women With Late-Stage Breast Cancer Is More Effective and Less Costly When FISH Diagnostic Technology Is Used |
22-Mar-2004 |
| Abbott Wins Depakote(R) Patent Infringement Lawsuit Against TorPharm |
15-Mar-2004 |
| JUVEN Added to Abbott Laboratories' Nutritional Product Line for People With Cancer, HIV/AIDS and Wounds/Pressure Ulcers |
12-Mar-2004 |
| Abbott Laboratories Employees Honored For Exceptional Performance With Chairman's Award |
10-Mar-2004 |
| Abbott Laboratories Secures Contract Amendment for Blood Screening Test |
10-Mar-2004 |
| Abbott and Seradyn Announce U.S. Clearance for Hemoglobin A(1C) (HbA(1C)) Test For Diabetes |
5-Mar-2004 |
| Abbott Laboratories and Corixa Enter Into Agreement for Chagas' Disease Blood Screening Technology |
2-Mar-2004 |
| Abbott and Europroteome Announce Research Collaboration to Develop Diagnostic Tests for Breast Cancer |
1-Mar-2004 |
| Abbott Scholar Award in Rheumatology Given to Promising Researchers |
27-Feb-2004 |
| New Sinus and Allergy Guidelines Recommend Omnicef(R) as First-Line Treatment Option for Acute Bacterial Sinusitis |
26-Feb-2004 |
| Abbott Laboratories Supports FDA's Final Bar Code Rule |
25-Feb-2004 |
| Abbott Laboratories Acquisition of TheraSense Clears Antitrust Review |
24-Feb-2004 |
| Abbott Laboratories, Working Mother Media Join Forces to Promote Workplace Support for Breastfeeding |
20-Feb-2004 |
| Abbott Laboratories Declares 321st Consecutive Quarterly Dividend |
20-Feb-2004 |
| New Data Suggest Potential for Once-Daily Dosing Regimen of Kaletra(R) (Lopinavir/Ritonavir) in HIV Treatment-Naive Patients |
12-Feb-2004 |
| Abbott Receives Approval for 11 Diagnostic Tests |
9-Feb-2004 |
| Abbott Laboratories Announces Positive Results of Phase II HUMIRA(R) (adalimumab) Study in Psoriasis |
9-Feb-2004 |
| Abbott Laboratories Initiates Phase III Clinical Trial to Explore Use Of HUMIRA(R) (adalimumab) in Ankylosing Spondylitis |
4-Feb-2004 |
| Abbott Laboratories and Caprion Pharmaceuticals Announce Drug Discovery Collaboration in Oncology |
4-Feb-2004 |
| Abbott Laboratories and Raven biotechnologies Establish Research Collaboration For Antibody Therapeutics |
3-Feb-2004 |
| Abbott and Axis-Shield Announce U.S. Clearance for AxSYM BNP Test for Heart Failure |
3-Feb-2004 |
| Abbott Laboratories Names Richard Ashley As New Executive Vice President, Corporate Development |
2-Feb-2004 |
| Abbott Laboratories Completes Final Step in Acquisition of i-STAT Corporation |
30-Jan-2004 |
| Abbott Laboratories Acquires Control of i-STAT Corporation |
28-Jan-2004 |
| Abbott Laboratories Names James White, Director, Federal Government Affairs, To Expand Washington D.C. Staff |
27-Jan-2004 |
| Abbott Laboratories Wins Contract for Blood Screening Tests and Instruments |
27-Jan-2004 |
| Abbott Vascular Devices Launches U.S. Commercial Operations of Endovascular Technologies Unit |
26-Jan-2004 |
| Abbott CEO to Present at Merrill Lynch Pharmaceutical, Biotechnology And Medical Device Conference |
22-Jan-2004 |
| Abbott Laboratories to Present at U.S. Bancorp Piper Jaffray Health Care Conference |
22-Jan-2004 |
| Abbott Laboratories Acquisition of i-STAT Corporation Receives Antitrust Clearance |
21-Jan-2004 |
| Abbott Reports 14.3 Percent Sales Increase in the Fourth Quarter; 11.3 Percent Increase For 2003 |
16-Jan-2004 |
| Abbott Laboratories to Acquire TheraSense |
13-Jan-2004 |
| Abbott Laboratories Submits Application to U.S. Department of Agriculture For Mad Cow Disease Test |
12-Jan-2004 |
| Abbott Laboratories Announces Agreement With Atria Genetics for HLA Tissue Typing Tests |
12-Jan-2004 |
| Abbott Laboratories' HUMIRA(R) (Adalimumab) Marks Successful First Year Treating Patients With Rheumatoid Arthritis |
30-Dec-2003 |
| Make the Commitment: Diabetes Weight Loss Solutions That Work |
30-Dec-2003 |
| AmeriCares and Abbott Laboratories Respond to Earthquake Devastation in Iran With Needed Medical Supplies |
30-Dec-2003 |
| Abbott Laboratories' Diagnostic Manufacturing Operations in Substantial Conformity with Quality System Regulation |
18-Dec-2003 |
| Abbott Laboratories' Annual Charitable Giving Campaign Results in $6.3 Million Contribution |
17-Dec-2003 |
| Abbott Laboratories Hosts Conference Call for Fourth-Quarter and Full-Year 2003 Earnings |
17-Dec-2003 |
| Abbott Announces Purchasing Agreement with Premier for MediSense Point-of-Care Products |
16-Dec-2003 |
| Abbott Laboratories Names Executive to Lead Ross Products Division |
15-Dec-2003 |
| Abbott Laboratories to Acquire i-STAT Corp., a Leading Manufacturer of Point-of-Care Diagnostics |
15-Dec-2003 |
| Abbott Laboratories Declares 320th Consecutive Quarterly Dividend |
12-Dec-2003 |
| New Data Presented at Neonatology Conference Suggest More Needs to Be Done To Protect At-Risk Infants From Respiratory Syncytial Virus |
12-Dec-2003 |
| 'Hospira' Selected as Company Name by Employees of Abbott Laboratories' New Hospital Products Company |
11-Dec-2003 |
| Abbott Laboratories Announces Agreement with Wyeth to Develop an Automated Test to Monitor Transplant Drug |
9-Dec-2003 |
| Abbott MedNet(TM) Drug Library Software Sets New Industry Standard For Medication Management in Hospitals |
8-Dec-2003 |
| Abbott and Axis-Shield Announce US 510(K) Submission and Non-US Launch Of AxSYM(R) BNP Test for Heart Failure |
8-Dec-2003 |
| Abbott Laboratories Introduces Enhanced Version of MediSense Precision PCx(TM) System |
3-Dec-2003 |
| New Study Published in JAMA Demonstrates Important Role for Aggressive Management of Hypertension in Patients With Coronary Artery Disease |
2-Dec-2003 |
| Help Stop Diabetes Holiday Food Frustration; No Need to Give Up Taste This Year |
25-Nov-2003 |
| New Data Show U.S. Breastfeeding Rates at All-Time Recorded High |
25-Nov-2003 |
| Abbott Laboratories Demonstrates Commitment to Environmental Excellence And Pollution Prevention |
24-Nov-2003 |
| PREVACID(R) NapraPAC(TM) Approved by U.S. Food and Drug Administration For Patients Taking NSAIDs for the Treatment of Arthritis Who Are at Risk For Recurrent Gastric Ulcers |
19-Nov-2003 |
| Abbott Laboratories' Ross Products Division to Market Collagenase SANTYL(R) Ointment |
14-Nov-2003 |
| Abbott Laboratories Launches Global Research Program to Study Effects Of D-Receptor Activation in Patients With Chronic Kidney Disease |
14-Nov-2003 |
| Abbott Laboratories' Ross Products Division Captures Best Taste Award for New Glucerna(R) Weight Loss Shakes for People With Diabetes |
6-Nov-2003 |
| European Commission Approves Synagis(R) Use in Young Children With Congenital Heart Disease to Prevent Serious Respiratory Syncytial Virus Infection |
30-Oct-2003 |
| Abbott Laboratories Honors Outstanding Scientists and Engineers For Scientific Excellence, Leadership and Innovation |
28-Oct-2003 |
| Abbott Laboratories and artus Introduce Automated Diagnostic Tests for SARS And Other Infectious Diseases |
28-Oct-2003 |
| More Than 100 Local School Children Learn About Drug Discovery At First-Ever Science Day At Abbott Bioresearch Center |
28-Oct-2003 |
| Ensure(R) Makes A Run For Healthy, Active Adults |
27-Oct-2003 |
| Results From Study With Kaletra(R)-Based Regimen Showed No Evidence of PI Resistance in HIV Treatment-Naive Patients Through Five Years |
27-Oct-2003 |
| New Data Show Abbott Laboratories' HUMIRA(R) (Adalimumab) Significantly Improves Quality of Life in Rheumatoid Arthritis Patients |
27-Oct-2003 |
| Abbott Laboratories' HUMIRA(R) (Adalimumab) Demonstrates Sustained Response, Tolerability over Five Years in Adult Rheumatoid Arthritis Patients |
24-Oct-2003 |
| Abbott Laboratories Ranked Among Top 20 Employers for Scientists in The Biotechnology and Pharmaceutical Industries |
23-Oct-2003 |
| More Than 100 Local School Children to Attend First-Ever Science Day at Abbott Bioresearch Center in Worcester |
23-Oct-2003 |
| Abbott Reports 11.6 Percent Sales Increase in the Third Quarter |
9-Oct-2003 |
| Abbott Laboratories' HUMIRA(R) (adalimumab) Receives Award as One of Chicago's Top Innovations |
8-Oct-2003 |
| Abbott Laboratories Expands HUMIRA(R) (adalimumab) Clinical Trial Program In Psoriatic Arthritis |
6-Oct-2003 |
| Abbott Laboratories Hosts Conference Call for Third-Quarter Earnings |
2-Oct-2003 |
| Abbott Laboratories Announces Submission for HUMIRA(R) (Adalimumab) to Improve Physical Function in Rheumatoid Arthritis Patients |
1-Oct-2003 |
| Abbott Laboratories Expands HUMIRA(R) (adalimumab) Clinical Trial Program In Crohn's Disease |
29-Sep-2003 |
| Abbott Announces Acquisition of Integrated Vascular Systems, Inc. |
26-Sep-2003 |
| Working Mother Magazine Identifies Abbott Laboratories Among Companies Doing More for Employees With 'Tweens,' Children Too Old for Day Care and Too Young To Be Left Alone at Home |
23-Sep-2003 |
| Abbott Laboratories and Boehringer Ingelheim Donate Test Kit and AIDS Drug to Help Prevent Mother-to-Child Transmission of HIV |
23-Sep-2003 |
| Modernized Hospital Will Improve HIV/AIDS Care In Tanzania |
22-Sep-2003 |
| Abbott Announces 30-Day Results of Clinical Trial for Carotid Artery Stent And Filter System |
19-Sep-2003 |
| Abbott Laboratories to Present at Merrill Lynch Pharmaceuticals Conference |
17-Sep-2003 |
| Rheumatoid Arthritis Awareness Campaign Plants a 'Can-Do' Spirit in Patients |
16-Sep-2003 |
| Kaletra-Based Regimen Demonstrated Viral Suppression for Patients New To Therapy in Five-Year HIV Trial |
15-Sep-2003 |
| Abbott Laboratories Names Executive to Lead Worldwide Diagnostics Business |
15-Sep-2003 |
| Prominent Journal Reports Benefits of Specialized Nutritional Product For People with Cancer-Related Weight Loss |
12-Sep-2003 |
| Abbott Laboratories Declares 319th Consecutive Quarterly Dividend |
12-Sep-2003 |
| Abbott Laboratories to Present At Banc of America Securities Investment Conference |
11-Sep-2003 |
| Abbott Laboratories and the Occupational Health and Safety Administration Announce Alliance |
10-Sep-2003 |
| Abbott Laboratories Announces European Union Approval of HUMIRA(R) for The Treatment of Adult Rheumatoid Arthritis |
10-Sep-2003 |
| Abbott Laboratories' Once-Daily Depakote(R) ER (Divalproex Sodium Extended- Release) Receives FDA Approval for Pediatric Use |
9-Sep-2003 |
| Kaletra(R) Recommended by Department of Health and Human Services Panel As Part of Preferred Protease Inhibitor-Based Regimen for Initial Treatment Of HIV |
5-Sep-2003 |
| Abbott Laboratories to Present at Bear Stearns Health Care Conference |
2-Sep-2003 |
| Abbott Laboratories to Add Capacity and Jobs at Ross Products Plant in Casa Grande |
28-Aug-2003 |
| Abbott Laboratories Completes Acquisition of ZonePerfect Nutrition |
27-Aug-2003 |
| Three Chemists from Abbott Laboratories Named Heroes for Discovery of HIV Therapy Kaletra(R) (Lopinavir/Ritonavir) |
26-Aug-2003 |
| Abbott Laboratories to Create Global Public Hospital Products Company With $2.5 Billion in Sales |
22-Aug-2003 |
| Abbott Laboratories to Host Conference Call with Investors and Analysts Regarding Strategic Announcement |
21-Aug-2003 |
| Abbott Laboratories and Millennium Pharmaceuticals End Research Alliance |
15-Aug-2003 |
| Ensure(R) Kicks the Can to Provide 'On-the-Go' Nutrition for Healthy, Active Lifestyles |
5-Aug-2003 |
| Abbott Laboratories and LigoCyte Pharmaceuticals Announce Research Collaboration for Monoclonal Antibody |
4-Aug-2003 |
| Retrospective Analysis of Hemodialysis Treatment Data Suggests that Zemplar(R) (Paricalcitol Injection) Was Associated With a Higher Survival Rate Than Calcijex(R) (Calcitriol Injection) |
31-Jul-2003 |
| Abbott Laboratories Announces Launch of Enhanced Perclose A-T(TM) |
29-Jul-2003 |
| Abbott Laboratories and Dharmacon Collaborate to Develop siRNA Library For Identification of New Drug Targets |
29-Jul-2003 |
| European Medicines Evaluation Agency Grants Abbott Laboratories Positive Opinion for Synagis(R) Use in Young Children With Congenital Heart Disease To Prevent Serious Respiratory Syncytial Virus Infection |
28-Jul-2003 |
| Abbott Laboratories to Acquire ZonePerfect Nutrition |
24-Jul-2003 |
| Ross Products Division Reaches Settlement Related to Industry-Wide Enteral Nutrition Investigation |
23-Jul-2003 |
| Abbott Laboratories Expands Hematology Product line with CELL-DYN(R) 1800 System |
17-Jul-2003 |
| Abbott Laboratories Introduces Enhancements to the AxSYM(R) Automated Immunoassay System |
16-Jul-2003 |
| Abbott Laboratories to Preview Remote Diagnostics Technology at the American Association for Clinical Chemistry Annual Meeting |
15-Jul-2003 |
| HIV Patients Experiencing Moderate Side Effects Reported Improved Outcomes When Changed to a Regimen Containing Kaletra(R) |
14-Jul-2003 |
| Abbott Reports 9.5 Percent Sales Increase in the Second Quarter |
10-Jul-2003 |
| Abbott Laboratories Hosts Conference Call for Second-Quarter Earnings |
8-Jul-2003 |
| Abbott Laboratories Named Among FORTUNE's '50 Best Companies for Minorities' For Sixth Consecutive Year |
7-Jul-2003 |
| Abbott Completes Asset Purchase of JOMED's Coronary and Peripheral Business Line |
30-Jun-2003 |
| Ross Products Division Anticipates Settlement of Enteral Nutrition Investigation |
26-Jun-2003 |
| Abbott Laboratories Sponsors Free HIV Testing Program for Communities at Risk |
25-Jun-2003 |
| Abbott Laboratories Declares 318th Consecutive Quarterly Dividend |
20-Jun-2003 |
| Abbott Laboratories Presents New HUMIRA(TM) (adalimumab) Data Showing Effectiveness in Adult Rheumatoid Arthritis Patients With Early And Established Disease and Sustained Response Up to Four Years |
19-Jun-2003 |
| Abbott Laboratories Appoints Vice President, Europe Operations, Abbott International |
17-Jun-2003 |
| Abbott Laboratories Appoints Vice President, Diagnostic Commercial Operations |
17-Jun-2003 |
| Abbott laboratories, ACR/REF Announce Program for Rheumatology Residents |
12-Jun-2003 |
| Abbott Laboratories' Internship Program Receives Top Ratings By The Princeton Review |
12-Jun-2003 |
| Abbott Laboratories to Present at the Goldman Sachs Global Health Care Conference |
6-Jun-2003 |
| Abbott Laboratories' Investigational Angiogenesis Inhibitor Shows Activity And Demonstrates No Dose-Limiting Toxicities in Phase 1 Study |
3-Jun-2003 |
| Ross Products Division, Abbott Laboratories Announces Launch of Glucerna(R) Weight Loss Shakes To Help Address Weight Management Needs of People with Diabetes |
3-Jun-2003 |
| Abbott Laboratories to Acquire Spinal Concepts |
2-Jun-2003 |
| India Advances Efforts for Children Affected by HIV/AIDS |
30-May-2003 |
| Abbott Laboratories Reviews Pharmaceutical Research and Development Transformation at Meeting for Investors and Financial Analysts |
29-May-2003 |
| Abbott Laboratories' Ross Products Division Announces Alimentum(R) Advance(R) -- the First Protein Hydrolysate Formula Supplemented with DHA and ARA |
29-May-2003 |
| Abbott Signs Asset Purchase Agreement for JOMED's Coronary and Peripheral Interventional Business Line |
27-May-2003 |
| Abbott Laboratories Hosts Webcast for 2003 R&D Update Meeting with Investors And Financial Analysts |
22-May-2003 |
| Abbott's PathVysion(R) Gene Test Gaining Ground as Standard of Care In Diagnosis of Deadly Form of Breast Cancer |
22-May-2003 |
| European Medicines Evaluation Agency Grants Positive Opinion for Abbott Laboratories' Humira(TM) for the Treatment of Adult Rheumatoid Arthritis |
22-May-2003 |
| Abbott Laboratories and Promega Corp. Announce Agreement for Molecular Diagnostics Products |
19-May-2003 |
| Abbott Laboratories Enters Agreement with Artus GmbH for SARS Diagnostic Test |
15-May-2003 |
| Big Bottle Babies: Stranded Whales Are Recovering With a Product Designed To Help Sick Kids |
8-May-2003 |
| Abbott Laboratories Honors Employees for Superior Performance |
6-May-2003 |
| Abbott Laboratories Launches Interactive Web Site For Rheumatoid Arthritis Community |
29-Apr-2003 |
| Abbott Scholar Award in Rheumatology Granted to Promising Researchers |
29-Apr-2003 |
| Abbott Laboratories Introduces the LifeCare(R) PCA3 Infusion System, a State-of-The-Art Patient-Controlled Analgesia Device |
29-Apr-2003 |
| Abbott Laboratories Donates Products and Supplies to Aid Relief Efforts |
28-Apr-2003 |
| Abbott Laboratories Reviews 2002 Accomplishments At Annual Shareholders Meeting |
25-Apr-2003 |
| Abbott Laboratories and Cerner Corporation Collaborate to Bring New Point-Of-Care Systems to the Bedside |
25-Apr-2003 |
| Abbott Laboratories Enters Agreement With Medical Analysis Systems for West Nile Virus Test |
25-Apr-2003 |
| Abbott Reports 9.3 Percent Sales Increase in the First Quarter; EPS of $0.51 Meets Consensus Estimate |
9-Apr-2003 |
| 22,000 Patient INVEST Trial Shows Verapamil-Based Treatment Is Equal to Gold Standard in Reducing Mortality in High-Risk Cardiac Patients |
2-Apr-2003 |
| Abbott Laboratories Hosts Conference Call for First-Quarter Earnings |
1-Apr-2003 |
| Abbott Laboratories to Eliminate Millions of Needles From the U.S. Health care System |
27-Mar-2003 |
| Abbott Laboratories Completes Initiative to Bar Code 100 Percent of Its Hospital Injectable Pharmaceuticals and IV Solutions |
27-Mar-2003 |
| Abbott Laboratories Names Executives to Lead U.S. Pharmaceutical And International Businesses |
14-Mar-2003 |
| Abbott's Annual Charitable Giving Campaign Results In $6.6 Million Contribution |
6-Mar-2003 |
| Abbott Laboratories Honored With First Ever Pro Bono Partner Award |
4-Mar-2003 |
| Abbott Laboratories Initiates Clinical Trials to Explore Use of HUMIRA(TM) (adalimumab) in Psoriasis and Psoriatic Arthritis |
3-Mar-2003 |
| Abbott Laboratories Resumes Share Repurchase Program and Increases Quarterly Dividend |
14-Feb-2003 |
| Abbott Launches Dexamet(TM) Stent System in Europe |
11-Feb-2003 |
| Abbott Laboratories Provides Update on Phase III Atrasentan Clinical Trials In Men With Advanced Prostate Cancer |
10-Feb-2003 |
| Published Data from ARMADA Study with HUMIRA(TM) (adalimumab) Show Improvement In Disease Activity and Quality of Life Measures in Patients With Rheumatoid Arthritis (RA |
30-Jan-2003 |
| Abbott Laboratories and OraSure Technologies Introduce OraQuick(R) Rapid HIV-1 Antibody Test |
30-Jan-2003 |
| Abbott Reports 8.9 Percent Sales Increase in the Fourth Quarter - Delivers record sales and earnings in 2002 |
16-Jan-2003 |
| Abbott Laboratories and Luminex Corporation Enter Into License and Supply Agreements for In Vitro Diagnostic Technology and Products |
15-Jan-2003 |
| Abbott Laboratories and Compugen Announce Agreement for Identification and Prioritization of New Drug Targets |
15-Jan-2003 |
| Lupron Depot(R) (Leuprolide Acetate For Depot Suspension) Becomes First Product in Class to Offer Needle Safety Device |
14-Jan-2003 |
| Abbott Laboratories Hosts Conference Call for Fourth-Quarter and Full-Year 2002 Earnings |
13-Jan-2003 |
| Abbott Laboratories Announces Unprecedented Drug Access Program for New Rheumatoid Arthritis (RA) Drug, HUMIRA(TM) (adalimumab), for Medicare-Eligible Seniors |
6-Jan-2003 |
| Abbott Laboratories Supplies Newly Approved Rheumatoid Arthritis (RA) Medication, HUMIRA(TM) (Adalimumab) to U.S. Pharmacies This Week |
6-Jan-2003 |
| Abbott Laboratories to Host Conference Call Today to Discuss Early Approval For HUMIRA(TM) (adalimumab |
2-Jan-2003 |
| Abbott Laboratories to Host Conference Call on Thursday, Jan. 2, 2003, To Discuss Today's FDA Early Approval for HUMIRA(TM) (adalimumab |
31-Dec-2002 |
| Abbott Laboratories Receives FDA Approval Earlier Than Anticipated For HUMIRA(TM) (adalimumab) for the Treatment of Rheumatoid Arthritis (RA |
31-Dec-2002 |
| Abbott Laboratories Receives FDA Approval For Once-Daily Depakote(R) ER (Divalproex Sodium Extended-Release) Tablets For Certain Forms Of Epilepsy |
20-Dec-2002 |
| Study in Acute Mania Shows Fewer Patients Reported Side Effects With Mood Stabilizer Depakote(R) (Divalproex Sodium) Than the Antipsychotic Zyprexa(R) (Olanzapine |
16-Dec-2002 |
| Abbott Laboratories Declares 316th Consecutive Quarterly Dividend |
13-Dec-2002 |
| Abbott Laboratories and Tecan Announce an Agreement Covering Automated Sample Preparation Systems for Molecular Diagnostics |
5-Dec-2002 |
| Abbott Laboratories and MerLion Pharmaceuticals Announce Drug Discovery Collaboration |
26-Nov-2002 |
| Perclose A-T(TM) Simplifies Vessel Closure After Cardiac Catheterization Procedures |
20-Nov-2002 |
| Abbott Laboratories and Domantis Establish Research Collaboration |
4-Nov-2002 |
| Abbott Laboratories to Build Biotechnology Manufacturing Plant in Puerto Rico |
29-Oct-2002 |
| TAP Pharmaceutical Products Inc. Submits New Drug Application for UPRIMA(R) (Apomorphine HCL Tablets) Sublingual for Treatment of Erectile Dysfunction |
29-Oct-2002 |
| Abbott Laboratories' Ross Products Division Announces the Launch of Isomil(R) Advance(R) -- the First and Only Soy Formula Supplemented With DHA and ARA |
28-Oct-2002 |
| Abbott Laboratories Honored With Prestigious Quality Award for Excellence In Employee Assistance Programs |
28-Oct-2002 |
| Abbott Laboratories Endows the ACR/REF/Abbott Endowment for Rheumatology Development |
26-Oct-2002 |
| Abbott Laboratories Presents HUMIRA(TM) (adalimumab), Also Known As D2E7, PIVOTAL PHASE III Data in Rheumatoid Arthritis (RA) Patients |
25-Oct-2002 |
| Abbott Laboratories Launches RA.com, An Interactive Web Site For People With Rheumatoid Arthritis (RA) |
25-Oct-2002 |
| Abbott Laboratories Honors Outstanding Scientists and Engineers for Scientific Excellence, Leadership, and Innovation |
22-Oct-2002 |
| Abbott Laboratories Demonstrates Commitment to Environmental Excellence And Pollution Prevention |
18-Oct-2002 |
| Abbott Laboratories and Rigaku/MSC Recognized for Invention of Innovative Drug Discovery Tool |
16-Oct-2002 |
| Abbott Laboratories Receives FDA Approval to Reintroduce Abbokinase(R) (urokinase) |
10-Oct-2002 |
| Abbott Reports Third-Quarter Results; Announces D2E7 Access Study, Restructuring Plans |
9-Oct-2002 |
| Abbott Laboratories Announces Study to Make D2E7 (Adalimumab) Available to Rheumatoid Arthritis (RA) Patients in Need |
9-Oct-2002 |
| Abbott Laboratories' Kaletra(R) (lopinavir/ritonavir) Attains Status As Most-Prescribed Protease Inhibitor for the Treatment of HIV |
2-Oct-2002 |
| Abbott Laboratories Offers Local Students A Foundation for Science Discoveries |
30-Sep-2002 |
| Abbott Laboratories Awards Scholarships To Emerging Leaders In Rheumatology |
30-Sep-2002 |
| Abbott Laboratories Demonstrates Excellence In Information Technology Innovation |
24-Sep-2002 |
| Abbott Laboratories Recognized as One of the Top 10 Best Places to Work For Mothers Nationwide |
24-Sep-2002 |
| Abbott Laboratories' Ross Products Division Launches Preterm Infant Formulas Supplemented With DHA And ARA |
17-Sep-2002 |
| Abbott Laboratories Declares 315th Consecutive Quarterly Dividend |
13-Sep-2002 |
| FDA Approves Inclusion of Abbott's PathVysion(R) Gene Test in Herceptin(R) Labeling |
12-Sep-2002 |
| Abbott Laboratories Joins Forces With Industry Leaders to Advance Patient Care Through National Information Technology Alliance |
5-Sep-2002 |
| Abbott Laboratories Initiates Clinical Trials to Explore Use of D2E7 (adalimumab) in Juvenile Rheumatoid Arthritis (JRA) and Crohn's Disease |
4-Sep-2002 |
| Abbott Laboratories Fund Awards Summer Research Fellowships to Biomedical Research Students |
22-Aug-2002 |
| TAP Pharmaceutical Products Receives FDA Approval for Pediatric Labeling Of PREVACID(R) (Lansoprazole) |
5-Aug-2002 |
| Abbott Laboratories Announces Initiative to Reduce Risk Of Medication Errors in Hospitals, Pledges to Bar Code Injectable Pharmaceuticals and IV Solutions |
1-Aug-2002 |
| Abbott Laboratories' SYNTHROID(R) (Levothyroxine Sodium Tablets, USP) Confirmed Safe and Effective Through FDA approval |
24-Jul-2002 |
| Abbott Laboratories Announces Initiative to Help Reduce the Risk Of Medication Errors in Hospitals, Pledges to Bar Code Its Injectable Pharmaceuticals and IV Solutions |
24-Jul-2002 |
| Abbott Launches Needlestick Prevention Web Site |
18-Jul-2002 |
| Abbott Reports Growth in Sales and Earnings Per Share in Second Quarter; Confirms 2002 EPS Guidance |
11-Jul-2002 |
| Promising Three-Year Data Presented on Viral Suppression, Immune Response And Resistance in Naive Patients Taking a Kaletra(R) (Lopinavir/Ritonavir) Regimen |
7-Jul-2002 |
| European Medicines Agency Completes Comprehensive Assessment of Abbott's Meridia(R)/ Reductil(R) (Sibutramine C-IV), Issues Positive Opinion Reaffirming Product's Favorable Risk/Benefit Profile as ... |
27-Jun-2002 |
| Abbott Laboratories and Celera Diagnostics Form Alliance to Develop and Market Molecular Diagnostic Products |
24-Jun-2002 |
| Abbott Laboratories to Provide Free HIV Test to Assist Mother-To-Child Transmission Prevention Programs in Africa and Developing Countries; Applauds U.S. Government Initiative |
19-Jun-2002 |
| Abbott And OraSure Technologies Enter Distribution Agreement For OraQuick(R) Rapid HIV-1 Test In The United States |
17-Jun-2002 |
| First Phase III Data for Abbott Laboratories' D2E7 (Adalimumab) Support Promise in Rheumatoid Arthritis (RA) |
14-Jun-2002 |
| TAP Pharmaceutical Products Among First to Adopt PhRMA Marketing Code Of Ethics |
13-Jun-2002 |
| Abbott Adjusts Earnings Guidance |
11-Jun-2002 |
| Abbott Announces Management Changes In Diagnostics Division |
10-Jun-2002 |
| Abbott Laboratories Declares 314th Consecutive Quarterly Dividend |
6-Jun-2002 |
| Abbott Laboratories Named One of the Nation's Best Employers for Minorities |
24-May-2002 |
| Phase I Studies of Abbott Laboratories' Angiogenesis Inhibitor Show Promising Results in Multiple Solid Tumor Types |
21-May-2002 |
| Abbott Laboratories' Atrasentan (ABT-627) Demonstrates Potential Survival Benefit in Hormone-Refractory Prostate Cancer Patients |
18-May-2002 |
| Abbott Laboratories Completes Acquisition of Biocompatibles' Cardiovascular Stent Business |
7-May-2002 |
| Abbott Laboratories Highlights Year Of Achievements At Annual Meeting |
26-Apr-2002 |
| Abbott Laboratories Reports 17.7 Percent Sales Increase in the First Quarter (20.2 Percent Before Exchange), Earnings Per Share of 54 Cents; Submits Simultaneous Applications for D2E7 |
9-Apr-2002 |
| Abbott Wins Sole Supplier Contract For Blood Screening Tests |
9-Apr-2002 |
| Abbott Laboratories and the University of Zurich Collaborate to Develop Diagnostic Tests for BSE and CJD |
25-Mar-2002 |
| Abbott Laboratories to Increase Quarterly Dividend 11.9 Percent |
15-Feb-2002 |
| Aruffo to Succeed Retiring Kamen at Abbott Bioresearch Center |
1-Feb-2002 |
| Abbott Reports 20 Percent Sales Increase in the Fourth Quarter |
16-Jan-2002 |
| First Oral Suspension Formulation for a Proton Pump Inhibitor Now Available By Prescription |
14-Jan-2002 |
| Abbott Laboratories Hosts Conference Call for Fourth-Quarter and Full-Year 2001 Earnings |
14-Jan-2002 |
| FDA Approves Use of PathVysion(R) Breast Cancer Test to Select Appropriate Candidates for Herceptin(R) Therapy |
10-Jan-2002 |
| Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids |
10-Jan-2002 |
| Abbott Laboratories Exercises Option From Hayashibara To Antibodies Against Cytokine IL-18 |
9-Jan-2002 |
| Abbott Laboratories Obtains Exclusive License to Yeast Display Technology Through Acquisition of Virtual Company, BioDisplay Technologies, Inc |
21-Dec-2001 |
| Clarithromycin (Biaxin(R)) Active Against Anthrax in Vitro |
18-Dec-2001 |
| Encouraging Resistance Data in Anti-Retroviral Naive Patients Extended To Two Years For Abbott Laboratories' Kaletra (lopinavir/ritonavir |
18-Dec-2001 |
| Abbott Promotes Executive Vice Presidents; Names Gonzalez to Board Of Directors |
14-Dec-2001 |
| Abbott Laboratories Declares 312th Consecutive Quarterly Dividend |
14-Dec-2001 |
| Abbott's Annual Charitable Giving Campaign Results in $6.5 Million Contribution |
13-Dec-2001 |
| Abbott Laboratories' Benefits Program Receives National Recognition as One Of The Country's Best |
10-Dec-2001 |
| Abbott Laboratories Completes Final Step in Acquisition of Vysis, Inc. |
5-Dec-2001 |
| Abbott Laboratories Acquires Control of Vysis, Inc. |
30-Nov-2001 |
| Abbott Laboratories Acquisition of Vysis, Inc. Clears Antitrust Review |
23-Nov-2001 |
| Abbott Laboratories Donates $10,000 to the American Veterinary Medical Foundation |
13-Nov-2001 |
| Abbott Laboratories' Investigational Fully Human Anti-TNF therapy, D2E7 (Adalimumab), Shows Promise in Reducing the Signs and Symptoms of Rheumatoid Arthritis |
12-Nov-2001 |
| Abbott Laboratories Partners With Environmental Protection Agency to Find Alternative Power Resources |
9-Nov-2001 |
| Abbott Receives 2001 Governor's Pollution Prevention Award for Continuous Improvement |
31-Oct-2001 |
| Abbott Laboratories Commences Tender Offer For All Outstanding Shares Of Vysis, Inc |
31-Oct-2001 |
| Abbott Laboratories Announces Readiness Plan to Address Potential Public Health Needs |
26-Oct-2001 |
| Abbott Laboratories to Acquire Vysis, Inc., a Leading Genomic Disease Management Company |
24-Oct-2001 |
| TAP Promises PREVACID(R) Patient Satisfaction With Launch of Landmark Money-Back Guarantee Program |
22-Oct-2001 |
| Abbott Names New Vice President and Treasurer |
19-Oct-2001 |
| Abbott Chief Scientific Officer Elected to the American Academy of Arts And Sciences and the Institute of Medicine |
18-Oct-2001 |
| Abbott Laboratories Announces Executive Promotion |
12-Oct-2001 |
| Abbott Reports 26.0 Percent Sales Increase in the Third Quarter |
10-Oct-2001 |
| Abbott Names Executive to Lead U.S. Nutritional Business |
9-Oct-2001 |
| Abbott Laboratories' Family-Friendly Work Environment Wins National Recognition |
9-Oct-2001 |
| Weight Loss Shown in Preliminary Study Data With MERIDIA(R) and A Meal Replacement Product |
8-Oct-2001 |
| Abbott Laboratories Hosts Conference Call for Third-Quarter Earnings |
8-Oct-2001 |
| Statement by Thomas Watkins, President TAP Pharmaceutical Products Inc |
3-Oct-2001 |
| Abbott Laboratories Says Reserves Are Adequate to Cover Its Half of TAP Joint Venture Settlement |
3-Oct-2001 |
| Abbott Laboratories to Participate in Bear Stearns 'Virtual' Healthcare Conference |
24-Sep-2001 |
| Abbott Laboratories Recognized for Information Technology Leadership And Distinction |
21-Sep-2001 |
| Abbott Laboratories Honors Outstanding Scientists and Engineers For Scientific Excellence, Leadership, and Innovation |
21-Sep-2001 |
| TAP Supports Disaster Relief Efforts |
14-Sep-2001 |
| Abbott Laboratories Fund Provides Financial Support to Relief Efforts |
12-Sep-2001 |
| TAP Receives FDA Approval for New Cephalosporin Antibiotic SPECTRACEF(TM)(Cefditoren Pivoxil |
12-Sep-2001 |
| Abbott Laboratories to Participate in Bear Stearns Annual Healthcare Conference |
10-Sep-2001 |
| Abbott Laboratories Declares 311th Consecutive Quarterly Dividend |
6-Sep-2001 |
| Abbott Laboratories Launches New Programs to Help Working Parents, Community Gear Up for Back to School Child Care Needs |
29-Aug-2001 |
| Abbott Laboratories Receives FDA Approval For Community-Acquired Pneumonia (CAP) Indication For Biaxin(R) XL (Clarithromycin Extended-Release Tablets) |
6-Aug-2001 |
| Abbott Laboratories Submits New Drug Application for Synthroid(R) (levothyroxine sodium, USP) to FDA in Advance of Deadline |
1-Aug-2001 |
| Obesity Experts Highlight Importance of Addressing Obesity and Related Health Consequences |
24-Jul-2001 |
| Abbott Laboratories Gratified by Court's Decision Granting Preliminary Injunction Against Watson Pharmaceuticals' False Advertising Against Synthroid |
20-Jul-2001 |
| Abbott Laboratories Appoints New Corporate Vice President, Japan Operations, Abbott International Division |
16-Jul-2001 |
| Abbott Reports 24.4 Percent Sales Increase Before Exchange |
12-Jul-2001 |
| FDA Guidance on Levothyroxine Sodium Products Assures Synthroid(R) (Levothyroxine Sodium, USP) Will Remain on Market While NDA Reviewed |
12-Jul-2001 |
| Abbott Laboratories Hosts Conference Call For Second-Quarter Earnings |
9-Jul-2001 |
| Abbott Laboratories Launches Innovative Coronary Stent in the United States |
5-Jul-2001 |
| Abbott Laboratories Makes Three Corporate Vice President Appointments |
3-Jul-2001 |
| Abbott Laboratories Named One of the Nation's Best Companies for Minorities By FORTUNE Magazine |
2-Jul-2001 |
| Abbott Laboratories, MediSense Products Receives FDA Clearance for New Blood Glucose Monitoring Test Strip Utilizing TrueMeasure(TM) Advanced Technology |
22-Jun-2001 |
| Abbott Laboratories Hosts Pharmaceutical Research and Development Meeting For Investors and Financial Analysts |
21-Jun-2001 |
| Abbott Laboratories Hosts Webcast for Investor and Financial Analyst Meeting |
19-Jun-2001 |
| Abbott Laboratories Makes Five Corporate Vice President Appointments |
18-Jun-2001 |
| Abbott Helps Working Parents Balance Work/Life With Opening of On-Site Child Care Center |
14-Jun-2001 |
| Abbott Laboratories Asks Federal Court to Help Protect Patients Against Misleading Information About Synthroid(R) (levothyroxine sodium, USP |
12-Jun-2001 |
| Abbott Laboratories Declares 310th Consecutive Quarterly Dividend |
8-Jun-2001 |
| Abbott Laboratories and Pharmacosmos A/S Sign Agreement to License and Develop Next Generation Intravenous Iron Product for Dialysis Patients |
8-Jun-2001 |
| Abbott Laboratories Receives Governor's Award for Work/Life Initiatives |
7-Jun-2001 |
| Abbott Response to News Reports on Synthroid |
1-Jun-2001 |
| Abbott Names Executive to Lead U.S. Pharmaceutical Business |
25-May-2001 |
| Abbott Laboratories' Atrasentan (ABT-627) Showed Delay in Progression Of Hormone-Refractory Prostate Cancer in Phase II Study |
14-May-2001 |
| Abbott Laboratories' Atrasentan (ABT-627) Helped Patients Maintain Health State Consistent with Baseline As Measured by Quality of Life |
13-May-2001 |
| Data Suggests Abbott Laboratories' Atrasentan (ABT-627) Inhibits Progression Of Bone Metastases in End-Stage Prostate Cancer |
13-May-2001 |
| Abbott Laboratories to Submit New Drug Application for Synthroid(R) (levothyroxine sodium, USP |
30-Apr-2001 |
| Abbott Highlights Year Of Accomplishments |
27-Apr-2001 |
| Abbott Laboratories Adjusts Litigation Reserves |
20-Apr-2001 |
| Abbott Reports First-Quarter Results Meet Expectations |
12-Apr-2001 |
| Sof-Tact(TM), Breakthrough Alternate-Site Glucose Monitoring Technology Now Available for People with Diabetes |
11-Apr-2001 |
| Abbott Laboratories Hosts Conference Call for First-Quarter Earnings |
10-Apr-2001 |
| Abbott Laboratories Signs Agreement With Vysis for Genomic Cancer Tests |
5-Apr-2001 |
| Abbott Laboratories to Offer AIDS Drugs and Rapid Diagnostic Test at No Profit In Africa |
27-Mar-2001 |
| Abbott Laboratories Signs Agreement With Enfer Scientific for Mad Cow Disease (BSE) Tests |
15-Mar-2001 |
| Data Indicate Drug-Coated Stents May Improve Treatment of Coronary Artery Disease |
13-Mar-2001 |
| Millennium and Abbott Laboratories Form Strategic Alliance in Metabolic Disease |
12-Mar-2001 |
| Abbott Laboratories and NaPro BioTherapeutics File Paclitaxel ANDA |
6-Mar-2001 |
| Abbott Laboratories Announces Completion of Acquisition of BASF's Pharmaceutical Business |
2-Mar-2001 |
| Abbott Announces New Five-Year Agreement With AmeriNet for Needlestick Prevention Products |
15-Feb-2001 |
| Abbott Laboratories Elects Thomas C. Freyman Senior Vice President, Finance And Chief Financial Officer |
9-Feb-2001 |
| Abbott Laboratories to Increase Quarterly Dividend 10.5 Percent |
9-Feb-2001 |
| Abbott Laboratories Satisfies Key U.S. Antitrust Closing Condition For Acquisition of BASF's Pharmaceutical Business |
8-Feb-2001 |
| Encouraging 48-Week Protease Inhibitor Resistance Data Presented for Abbott Laboratories' Kaletra(TM) (Lopinavir/Ritonavir) in Patients Without Previous HIV Therapy |
7-Feb-2001 |
| Abbott Laboratories' CEO Miles D. White to Make Presentation at Merrill Lynch Conference |
5-Feb-2001 |
| Abbott Laboratories Signs Agreement with MedNova and Rubicon Medical For Vascular Products |
2-Feb-2001 |
| Abbott Provides Disaster Relief to El Salvador Earthquake Victims |
26-Jan-2001 |
| European Committee for Proprietary Medicinal Products Adopts Positive Opinion On Abbott Laboratories' UPRIMA(R) for Erectile Dysfunction |
25-Jan-2001 |
| Abbott Reports Increases in Sales, Earnings for Fourth-Quarter 2000; Sales Rise 6.8 Percent to $3.7 Billion |
16-Jan-2001 |
| Abbott Laboratories Hosts Conference Call for Fourth-Quarter and Full-Year 2000 Earnings |
12-Jan-2001 |
 |
